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Summary 
The budding yeast protein Rtt101 serves as a scaffold for the assembly of a variety 
of ubiquitin E3 ligase complexes. Both Rtt101 and its human counterpart CUL4 have 
been implicated in the maintenance of genomic integrity. In the absence of RTT101, 
cells are highly sensitive to the genotoxic agents MMS and CPT, which cause DNA 
damage that results in replication fork stalling in the ensuing S-phase of the cell 
cycle. The established roles and substrates of Rtt101 can only partially explain the 
striking drug sensitivity. 
In a genetic screen using Saccharomyces cerevisiae as a model organism we 
identified Mrc1 as a key suppressor of rtt101 drug sensitivity. Amongst others, Mrc1 
contributes to the activation of the intra S-phase checkpoint in response to replicative 
stress and couples the DNA helicase to the leading strand DNA polymerase ԑ.  
The rescue of rtt101 cells by MRC1 deletion depended on the presence of the Rad52 
protein, the central player of the budding yeast homologous recombination 
machinery. By employing separation of function alleles we determined that the loss of 
Mrc1’s checkpoint function was not sufficient to alleviate rtt101 drug sensitivity. 
Instead, the replicative function of Mrc1 seemed to be toxic for rtt101 cells. Our data 
suggested that Rtt101 does not target Mrc1 for proteolysis.  
We propose that the ubiquitination of Mrc1 (or an unknown factor regulating Mrc1) by 
Rtt101 modulates the replisome at the stalled fork, possibly inducing the uncoupling 
of the helicase from the polymerase. This could allow the production of ssDNA that 
might trigger replication fork repair or restart by a homologous recombination-based 
pathway. 
Telomeres, particularly short telomeres, are difficult to replicate regions of the 
genome. Telomere shortening during replicative senescence is a natural process in 
human somatic cells that can be mimicked in budding yeast by deletion of the 
catalytic subunit of telomerase, Est2. 
Rtt101 had been reported to prevent premature senescence. Our experiments 
showed that Rtt101 does not exert its protective function by influencing telomere 
length. Nor did the accumulation of spontaneous DNA damage that has been 
reported for rtt101 cells contribute to the acceleration of senescence. Deletion of 
RTT101 further compromised the viability of senescing rad52 est2 cells suggesting 
that the crucial action of Rtt101 at shortening telomeres does not involve a 
homologous recombination event. Surprisingly, mrc1 est2 cells also senesced fast 
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and were epistatic with rtt101 est2 cells. This indicates that during senescence 
Rtt101 and Mrc1 protect shortening telomeres through a common mechanism. This 
is in contrast to the situation at stalled replication forks after treatment with MMS or 
CPT. We speculate that Rtt101 and Mrc1 act in concert to prevent precocious 
senescence signalling by delaying the creation of subtelomeric ssDNA. 
Taken together, our results provide insights into how the Rtt101, and perhaps human 
CUL4, E3 ligase functions to promote genome stability in the face of replication 
stress and telomere shortening. 
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Zusammenfassung 
Das Protein der Bäckerhefe Rtt101 dient als Gerüst für den Aufbau verschiedener 
Ubiquitin-E3-Ligase-Komplexe. Rtt101 und CUL4, sein Gegenstück in menschlichen 
Zellen, tragen zum Erhalt der Unversehrtheit des Genoms bei. In Abwesenheit von 
Rtt101 reagieren Zellen hochempfindlich auf die genotoxischen Substanzen MMS 
und CPT. Diese verursachen DNA-Schäden, die in der darauffolgenden S-Phase die 
Replikationsgabel zum Stillstand bringen. Die bekannten Funktionen und Substrate 
der Rtt101-basierten Ubiquitin-E3-Ligase-Komplexe können die auffällige 
Empfindlichkeit gegenüber genotoxischen Substanzen nur teilweise erklären. 
In einem genetischen Screen mit dem Modellorganismus Saccharomyces cerevisiae 
identifizierten wir Mrc1 als entscheidenden Faktor für die Unterdrückung der 
Empfindlichkeit von rtt101-Zellen. Mrc1 trägt unter anderem zur Aktivierung des Intra-
S-Phase-Checkpoints als Reaktion auf Replikationsstress bei und koppelt die DNA-
Helikase an die den Leitstrang synthetisierende Polymerase ԑ. 
Für die Rettung der rtt101-Zellen durch die Deletion von MRC1 war das Protein 
Rad52 nötig, das ein zentraler Bestandteil der homologen Rekombinations-
maschinerie ist. Mithilfe von funktionsspezifischen Allelen konnten wir zeigen, dass 
der Verlust von Mrc1’s Checkpoint-Funktion nicht ausreichend war, um die 
Empfindlichkeit von rtt101-Zellen zu mindern. Stattdessen schien die 
Replikationsfunktion von Mrc1 für rtt101-Zellen schädlich zu sein. 
Unsere Daten legten nahe, dass Rtt101 nicht zur Proteolyse von Mrc1 beiträgt. Wir 
schlagen vor, dass die Ubiquitinierung von Mrc1 (oder eines noch unbekannten, 
Mrc1 regulierenden Faktors) durch Rtt101 das Replisom an der blockierten 
Replikationsgabel moduliert und möglicherweise die Helikase von der Polymerase 
entkoppelt. Dies würde zur Produktion einzelsträngiger DNA führen, was wiederum 
die Reparatur oder den Neustart der Replikationsgabel durch homologe 
Rekombination einleiten könnte. 
Telomere, insbesondere kurze Telomere, lassen sich nur schwer replizieren. Die 
Verkürzung der Telomere während der replikativen Seneszenz ist ein natürlicher 
Prozess in somatischen, menschlichen Zellen, der in Bäckerhefe durch die Deletion 
der katalytischen Untereinheit der Telomerase, Est2, imitiert werden kann. 
Es war bekannt, dass Rtt101 vorzeitige Seneszenz verhindert. Unsere Experimente 
zeigten, dass Rtt101 seine Schutzfunktion nicht durch Beeinflussung der 
Telomerlänge ausübt. Auch die Häufung spontaner DNA-Schäden, die in rtt101-
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Zellen stattfindet, beschleunigt die Seneszenz nicht. Die Deletion von RTT101 setzte 
die Lebensfähigkeit von seneszenten rad52 est2-Zellen weiter herab. Dies impliziert, 
dass die Funktion von Rtt101 an sich verkürzenden Telomeren nicht auf homologer 
Rekombination beruht. Überraschenderweise wurden auch mrc1 est2-Zellen 
vorzeitig seneszent und waren epistatisch mit rtt101 est2-Zellen. Dies zeigt an, dass 
Rtt101 und Mrc1 sich verkürzende Telomere seneszenter Zellen durch einen 
gemeinsamen Mechanismus schützen. Dies unterscheidet sich von der Situation an 
blockierten Replikationsgabeln nach der Behandlung mit MMS oder CPT. Wir 
spekulieren, dass Rtt101 und Mrc1 zusammenarbeiten, um die vorzeitige 
Signalisierung von Seneszenz zu verhindern, indem sie die Entstehung von 
subtelomerischer, einzelsträngiger DNA verzögern. 
Zusammengenommen bieten unsere Ergebnisse Einblicke, wie die Rtt101 E3-
Ligase, und vielleicht auch CUL4 in menschlichen Zellen, zur Stabilität des Genoms 
im Angesicht von Replikationsstress und Telomerverkürzung beiträgt. 
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1 Introduction 
1.1 Cells need to maintain genomic integrity in the face of endogenous 
and exogenous threats 
The maintenance of genomic stability is crucial for all organisms as mutations and 
genomic rearrangements can be the cause for a variety of pathological disorders or 
cell death. Threats to genomic integrity arise from DNA damage inflicted either by 
endogenous influences such as reactive metabolites or by exogenous DNA 
damaging factors like ionizing radiation, UV light or genotoxic agents. In addition, the 
replication of DNA during the S-phase of the cell cycle is a phase of particular 
vulnerability of the genome. Cells must be able to cope with various types of 
obstacles, which slow down or stall replication forks, and might lead to replication 
fork break down and double strand break (DSB) formation that can trigger genomic 
rearrangements. These obstacles include transcribing RNA polymerases, tightly 
bound non-histone protein-DNA complexes, natural replication slow zones and bulky 
DNA lesions (Branzei and Foiani 2009). 
In order to meet these challenges cells have developed an impressive array of 
mechanisms to survey, control and repair their genetic material. The cellular 
reactions to the different kinds of aberrant DNA structures that may arise during S-
phase or as a consequence of direct DNA lesions are conserved from yeast to 
humans. Since this study was done using budding yeast as a model organism, the 
following paragraphs will focus on the checkpoint and DNA damage response 
mechanisms of S. cerevisiae and point out parallel mechanisms of particular 
relevance to this study in human cells. 
1.2 DNA damage and stalled replication forks activate checkpoint 
signalling 
The concept of "checkpoints" was first introduced by Hartwell and Weinert and 
describes “controls that ensure the order of cell cycle events” (Hartwell and Weinert 
1989). Several checkpoints ensure that eukaryotic cells do not progress in the cell 
cycle in unfavourable conditions. At the G1 checkpoint (cell growth checkpoint) 
external and internal conditions are checked to allow or prevent cell cycle entry. The 
intra S-phase checkpoint delays replication if DNA damage or abnormal replication 
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intermediates are sensed in S-phase. The G2/M (or DNA damage checkpoint) 
prevents the initiation of mitosis unless DNA damage is repaired. The metaphase 
checkpoint (spindle checkpoint) blocks the separation of the duplicated 
chromosomes until each chromosome is attached to the spindle. In the following 
paragraphs the pathways triggered by the DNA damage checkpoint and the intra S-
phase checkpoint will be discussed.  
The two key players of the S. cerevisiae DNA damage checkpoint are the 
phosphatidylinositol 3-kinase-related kinases (PIKKS) Mec1 (ATR in humans) and 
Tel1 (ATM in humans). Activation of these two checkpoint proteins triggers the 
phosphorylation and activation of the two major effector kinases Rad53 (CHK2 in 
humans) and Chk1 (CHK1 in humans) via the mediators Rad9 (MDC1 and 53BP1 in 
humans) and Mrc1 (Claspin in humans). 
Tel1 responds mainly to DSBs, while Mec1 is activated by a variety of different 
lesions that trigger the generation of ssDNA as well as DSBs. DSBs are 
characterized by exposed DNA ends that can be bound by the MRX (Mre11-Rad50-
Xrs2) complex and the Ku70/80 heterodimer (Martin, Laroche et al. 1999, Lisby, 
Barlow et al. 2004, Wu, Topper et al. 2008). The MRX complex recruits Tel1/Mec1, 
which phosphorylates histone H2A forming P-H2A in the regions flanking the DSB. In 
higher eukaryotes it is the histone variant H2AX that is phosphorylated to form 
γH2AX. P-H2A or γH2AX is a hallmark of damaged DNA (Rogakou, Pilch et al. 1998, 
Redon, Pilch et al. 2003). It recruits numerous chromatin remodelling complexes to 
the site of damage and promotes binding of the mediator Rad9 to methylated histone 
H3 (H3K79Me), which recruits and activates the effector kinase Rad53 (Lisby, Barlow 
et al. 2004, Toh, O'Shaughnessy et al. 2006). 
Sae2 and the MRX complex initiate DSB resection, whereby the MRX complex 
additionally recruits Dna2, Exo1 and the Sgs1 helicase for continued and more 
extensive resection. Exposed ssDNA is quickly covered by RPA and becomes a 
signal for the recruitment of a number of checkpoint and repair proteins including the 
Mec1-Ddc2, the Rad24-RFC complex (RFC-like complex) and Ddc1-Mec3-Rad17 
complex (9-1-1 or PCNA-like complex). The Mec1-Ddc2 complex binds DNA via the 
Ddc2 component (Rouse and Jackson 2002). This allows Mec1 to phosphorylate 
nearby targets, which often overlap with those of Tel1, like histone H2A. Mec1 also 
phosphorylates the mediator Rad9, which recruits the effector kinase Rad53 for 
subsequent phosphorylation and activation by Mec1. The presence of both the RFC-
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like and the PCNA-like complexes are required for efficient phosphorylation of Rad53 
by Mec1 (de la Torre-Ruiz, Green et al. 1998). 
The generation of ssDNA and the subsequent activation of Mec1 is also common to 
the processing of lesions other than DSBs such as NER (Nucleotide Excision Repair) 
of UV-induced DNA photoproducts or BER (Base Excision Repair) and explains the 
more prominent role of Mec1 over Tel1 in checkpoint signalling in S. cerevisiae. 
 
Figure 1 Simplified overview of the checkpoint response to DNA damage and stalled 
replication forks in Saccharomyces cerevisiae. This figure was adapted from Harrison 
and Haber 2006, and Lisby and Rothstein 2009. The processes are explained in detail in the 
text. 
Endogenous and exogenous replication stress results in replication fork stalling and 
elicits signalling activities, which also result in Mec1 dependent Rad53 activation. 
The main contribution to Rad53 phosphorylation in S-phase is mediated by Mrc1 
(Mediator of the Replication Checkpoint) (Alcasabas, Osborn et al. 2001, Osborn and 
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Elledge 2003). However, the significance of the two mediators Rad9 and Mrc1 in 
replication stress varies depending on the precise kind of replication stress inflicted 
on the cell. 
Activated Rad53 mediates cell cycle arrest and transcriptional induction of repair 
proteins via its three main targets Cdc20, Cdc5 and Dun1. Inhibition of the interaction 
of APCCdc20 (Anaphase Promoting Complex) with Pds1 (Securin in human) by Rad53 
prevents Pds1 degradation, which is required for the entry into mitosis (Agarwal, 
Tang et al. 2003). Pds1 stabilization is also promoted by its hyperphosphorylation as 
a consequence of DNA damage, which depends on Mec1, Rad9 and Chk1, another 
Mec1 target. In addition, Rad53 also inhibits Cdc5 in order to inhibit mitotic exit and 
allow time for damage repair (Cheng, Hunke et al. 1998, Sanchez 1999). 
DNA damage induces a transcriptional response that is regulated by the Dun1 kinase 
and ensures that the elevated need for dNTPs during repair is met by transcriptional 
induction of ribonucleotide reductase (RNR) genes (Zhou and Elledge 1993, Zhao, 
Chabes et al. 2001, Zhao and Rothstein 2002). 
While the pathways resulting in checkpoint activation have been studied in detail, far 
less is known about how cells resume the cell cycle after successful repair. During 
this process called recovery, the checkpoint needs to be deactivated. In S. cerevisiae 
dephosphorylation of Rad53 by the phosphatases Pph3 and Ptc2 combined with 
degradation of Mrc1 by the SCFDia2 ubiquitin E3 ligase are proposed to contribute to 
checkpoint downregulation after MMS-induced damage in S-phase (O'Neill, Szyjka et 
al. 2007, Fong, Arumugam et al. 2013). Likewise, the human homologue of Mrc1, 
Claspin, is degraded in an SCF-βTrCP-dependent manner during recovery from 
replication stress (Mailand, Bekker-Jensen et al. 2006, Peschiaroli, Dorrello et al. 
2006). 
The processes described under 1.2 are examined from different points of view in the 
reviews listed here (Rouse and Jackson 2002, Harrison and Haber 2006, Lisby and 
Rothstein 2009, Branzei and Foiani 2010), which served as a basis for section 1.2. 
1.3 The rescue of stalled replication forks is crucial to maintain genome 
stability 
The assembly of the replisome occurs in a stepwise process that is tightly regulated. 
The minichromosome maintenance (MCM) helicase complex (Mcm2-7) is loaded 
onto origins of replication in G1 with the help of ORC/Cdc6/Cdt1 to form the pre-
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replicative complex (preRC). The addition of the MCM-associated factors Cdc45 and 
the GINS complex in S-phase triggers the formation of the active replisome. The 
S-phase replisome is complemented with DNA polymerase α-primase, which initiates 
each new Okazaki fragment of the lagging strand, DNA polymerase δ and DNA 
polymerase ε, which synthesize the lagging and leading strand, respectively. 
Accessory proteins involved in mediating DNA synthesis are replication factor C 
(RFC) and proliferating cell nuclear antigen (PCNA) (Branzei and Foiani 2010). 
At least two factors have been identified that couple the two main catalytic activities 
of DNA unwinding and DNA synthesis. Ctf4 interacts with the CMG helicase (Cdc45-
MCM-GINS) and polymerase α-primase and Mrc1 binds subunits of the CMG 
helicase and polymerase ε (Lou, Komata et al. 2008, Gambus, van Deursen et al. 
2009, Komata, Bando et al. 2009, Tanaka, Katou et al. 2009). A wealth of additional 
regulatory proteins contributes to form the fully functional replisome. 
Replication fork stalling occurs frequently under normal growth conditions due to 
tightly bound protein DNA complexes, collisions of the DNA replication machinery 
with transcribing RNA polymerases or DNA lesions. Since the formation of new pre-
replicative complexes is restricted to G1, the breakdown of a replication fork by 
dissociation of essential replisome components from the stalled fork during S-phase 
is considered an irreversible event (Labib 2000). Replication fork stalling can lead to 
replication fork breakdown, which results in gapped molecules representing 
hemireplicated DNA. The exposition of long stretches of ssDNA and four-branched 
structures due to reversed forks are highly recombinogenic and may lead to gross 
chromosomal rearrangements and the appearance of DSBs due to nucleolytic 
cleavage of aberrant recombination intermediates (Takeuchi, Horiuchi et al. 2003, 
Ahn, Osman et al. 2005, Lambert, Watson et al. 2005, Branzei and Foiani 2009). 
Thus, the stabilization of stalled forks and their controlled restart becomes an issue of 
utmost importance in the maintenance of genome stability. 
Mrc1, Tof1 and Csm3 form a heterotrimeric complex that is part of the replisome 
during normal fork progression as well as upon HU-induced fork stalling. In both 
situations it contributes to the stabilization of the replisome by preventing the 
uncoupling of replication proteins from the replicated DNA (Katou, Kanoh et al. 2003, 
Bando, Katou et al. 2009). 
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Figure 2 Mechanisms for resumption of replication after replication fork arrest due to a 
DNA lesion on the leading strand. Template unwinding seems to occur beyond the site 
of damage and is uncoupled from leading strand synthesis creating a ssDNA gap. 
Bypass of the damage can occur via different pathways. (A) Transient recruitment of a TLS 
polymerase is a mutagenic mechanism that depends on PCNA modification. (B) Repriming 
on the leading strand leaves a ssDNA gap that can be filled postreplicatively by TLS or by an 
error-free recombination-mediated mechanism (template switching). (C) RF cleavage creates 
one-ended DSBs that can be repaired by break-induced replication (BIR) using the sister 
chromatid as a template. Adapted from (Yeeles, Poli et al. 2013) 
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Mrc1 and to a lesser extent Tof1 are also required for the full activation of the 
checkpoint response (Alcasabas, Osborn et al. 2001, Foss 2001, Osborn and 
Elledge 2003), which ensures repair and replication fork restart by a number of 
different mechanisms including translesion synthesis (TLS), template switching and 
break-induced replication (BIR). 
Continuous synthesis through DNA lesions is possible through the recruitment of 
lesion-bypass DNA polymerases, which temporarily replace the replicative 
polymerases and mediate a process called translesion synthesis (TLS). TLS is an 
error-prone mechanism. 
Recruitment of lesion-bypass polymerases depends on the ubiquitination of PCNA by 
the Rad6-Rad18 heterodimer (Moldovan, Pfander et al. 2007). Repriming on the 
leading strand leaves ssDNA gaps that can be filled by postreplicative TLS or by 
error-free recombination-dependent template switching. 
Failed replication fork restart and nucleolytic cleavage of aberrant recombination 
intermediates that are formed in this process can give rise to one-ended DSBs. 
Break-induced replication and sister chromatid recombination are homology-
mediated recombination mechanisms that depend on Rad52 (Cortes-Ledesma, Tous 
et al. 2007). It is noteworthy that all of these mechanisms require the controlled 
decoupling of the DNA unwinding activity from the DNA synthesis activity of the 
replisome and therefore the physical separation of the CMG helicase complex from 
polymerase ε (in the case of leading strand damage) as shown in Figure 2. 
Alternatively, fork regression can also precede template switching and HR-mediated 
fork restart. The causes, consequences and possible repair and restart mechanisms 
of stalled replication forks are reviewed in (Branzei and Foiani 2009, Branzei and 
Foiani 2010, Yeeles, Poli et al. 2013). These reviews served as a basis for 
section 1.3. 
Despite the efforts and the progress that have been made in understanding the 
regulation of replication and the mechanisms available to counteract replication fork 
breakdown and to promote genome stability during replication stress there is still a lot 
to learn about the role of many proteins that, when mutated, cause replication 
defects. The budding yeast proteins Rtt101 and Rtt107 have both been shown to be 
involved in replication fork restart. In response to DNA damage Rtt107 is 
phosphorylated by Mec1 and is thought to function as a scaffold recruiting repair 
proteins to the site of damage, including the endonuclease Slx4 and the SMC5/6 
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complex (Ohouo, Bastos de Oliveira et al. 2010, Leung, Lee et al. 2011). Rtt101 is a 
member of the cullin family of proteins and assembles ubiquitin E3 ligase complexes. 
Rtt101 is required for efficient resumption of replication after MMS treatment (Luke, 
Versini et al. 2006). Rtt101 and Rtt107 likely localize to chromatin as a complex upon 
replication fork stalling, where they might promote recovery by sister-chromatid 
recombination (Duro, Vaisica et al. 2008, Roberts, Zaidi et al. 2008). The molecular 
mechanism, however, remains elusive. 
1.4 Endogenous and exogenous factors cause a variety of DNA lesions 
DNA lesions occur frequently in the absence of external damaging agents. 
Metabolites such as reactive oxygen species (ROS) can damage the DNA in many 
ways, producing base modifications, abasic sites or non-conventional single-strand 
breaks. DNA integrity can also suffer from spontaneous hydrolysis resulting in 
deamination of bases and abasic sites. (Lindahl 1993, Waris and Ahsan 2006). 
Exogenous threats to the genome include UV light, ionizing radiation and chemical 
agents. UV light generates pyrimidine dimers as the most common lesion, while 
ionizing radiation creates DSBs as the most toxic of its DNA lesions. 
Methylmethane sulfonate (MMS) adds methyl groups to DNA bases. It has been 
used for decades as a "radiomimetic" drug. DSBs, however, do not seem to be a 
direct consequence of MMS treatment, but result from repair/replication 
intermediates that lead to strand breaks by aberrant processing or replication fork 
collapse (reviewed in Wyatt and Pittman 2006). 
Topoisomerases are specialized DNA nucleases that relieve torsional stress, which 
arises during DNA replication, transcription or chromatin remodelling, by inducing 
and resealing DNA breaks. Top1 travels with the replication fork and removes 
positive supercoiling ahead of the fork by introducing a single-strand break (nick). 
The anticancer drug camptothecin (CPT) stabilizes the otherwise transient DNA-
enzyme intermediate called cleavage complex and prevents religation. Collisions of 
the replication machinery with this stabilized protein-DNA complex cause DNA 
lesions and DSBs (Pommier 2006). 
Hydroxyurea (HU) is a widely used drug to induce replication stress. It reversibly 
inhibits ribonucleotide reductase (RNR). In response to diminished cellular nucleotide 
pools replication is slowed down and replication forks stall (Alvino, Collingwood et al. 
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2007). Zeocin is a glycopeptide antibiotic, whose deleterious effects arise from the 
generation of both DSBs and single-stranded nicks (Povirk 1996, Burger 1998). 
Since HU treatment interferes with normal replication it activates the S-phase 
checkpoint, while DSB induction by Zeocin triggers the DNA damage checkpoint. 
Both MMS and CPT cause DNA damage that is exacerbated by DNA replication and 
thus have the capability of activating both the DNA damage and the S-phase 
checkpoint depending on the drug concentration and the cell cycle stage of cells 
treated. 
1.5 Telomeres protect the ends of linear chromosomes from being 
recognized as DNA damage 
Telomeres are the nucleoprotein structures at the end of linear chromosomes. 
Telomeres protect the natural chromosome ends from being recognized as DNA 
damage due to their similarity with DSBs. Thus, one of the main functions of 
telomeres is to solve the so-called "end protection problem". The other main function 
is to solve the "end replication problem", which will be discussed in the next section. 
The mechanisms telomeres employ to meet these challenges depend on the 
repetitive telomeric DNA sequence, the proteins localizing to telomeres and the 
structure of telomeric DNA. These main telomeric features are conserved from yeast 
to human (Blackburn, Greider et al. 2006). 
Budding yeast telomeres consist of double-stranded, non-nucleosomal TG1-3 repeats 
and a single-stranded 3' G-rich overhang. Wild type yeast telomeres are roughly 275-
375 bp long. The overhang comprises about 12-15 nucleotides and increases to up 
to 30 nt in late S-phase, when telomeres are replicated and subsequently processed 
(Wellinger, Wolf et al. 1993, Soudet, Jolivet et al. 2014). 
It has been shown that human telomeres, which are about 10-15 kb long ending in a 
G-strand overhang of about 50-200 nt, can fold back and invade the ds telomeric 
DNA forming a t-loop (Griffith, Comeau et al. 1999). Budding yeast telomeres are 
thought to maintain a similar structure with the tip of the telomere being tethered to 
the subtelomeric region by protein-protein interactions. Telomere looping likely 
contributes to the protection of telomeres by inhibiting homologous recombination 
and telomere-fusions by NHEJ (Poschke, Dees et al. 2012). 
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Figure 3 Simplified telomere structure in S. cerevisiae. Telomeric dsDNA is bound by 
Rap1, which recruits Rif1 and Rif2. The Rap1/Rif1/Rif2 complex is crucial for telomere 
protection and length homeostasis. The Rap1 binding proteins Sir2, Sir3 and Sir4, which 
contribute to the heterochromatic structure of telomeric and subtelomeric DNA, are not 
shown. The single-stranded overhang is bound by Cdc13, which recruits Stn1 and Ten1 
forming the CST complex. The CST complex also takes part in the protection of telomeres 
and the regulation of telomere length. Telomere looping is not shown in this figure. 
The region adjacent to the telomere is called the subtelomere and contributes to 
telomere function. Subtelomeres are characterized by low gene density and possess 
specialized subtelomeric repetitive elements. All budding yeast subtelomeres harbour 
a so-called X element, while about half of the 32 chromosome ends additionally 
possess between one and four copies of a sequence termed the Y' element 
(Walmsley, Chan et al. 1984). 
Telomeres recruit a specialized set of proteins. In humans, a subset of these proteins 
has been termed the Shelterin complex, consisting of TRF1, TRF2, TIN2, RAP1, 
TPP1 and POT1 (de Lange 2005). S. cerevisiae is equipped with a "shelterin-like" 
complex consisting of Rap1, Rif1 and Rif2. Rap1 binds to the double-stranded part of 
yeast telomeres and recruits Rif1 and Rif2. The single-stranded overhang is bound 
by Cdc13, which interacts with Stn1 and Ten1, which together form the CST 
complex. Together, these proteins perform a variety of functions that help maintain 
telomeric integrity. 
The essential protein Rap1 plays a crucial role in the suppression of checkpoint 
activation by telomeres, in the establishment of silent chromatin in the subtelomeric 
region and in telomere length homeostasis. Rap1 counteracts the recruitment of the 
MRX complex to telomeres, prevents telomere fusions by NHEJ and inhibits Tel1 
binding to telomeres through Rif1 and Rif2 (Pardo and Marcand 2005, Hirano, 
Fukunaga et al. 2009). Rap1 also recruits the silent information regulators Sir2, Sir3 
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and Sir4 to telomeres, which spread into the subtelomeric region and establish a 
heterochromatic state by deacetylating H4K16 (Cockell, Palladino et al. 1995, Luo, 
Vega-Palas et al. 2002). This contributes to the "telomere positioning effect" (TPE), 
referring to the phenomenon that genes artificially placed in the subtelomeric region 
are transcriptionally repressed (Gottschling, Aparicio et al. 1990). Moreover, Cdc13, 
Stn1 and Ten1 prevent the binding of RPA to telomeric ssDNA and the subsequent 
activation of the Mec1-dependent checkpoint cascade and recruitment of DNA repair 
proteins. 
However, telomere protection does not simply depend on the exclusion of proteins 
pertaining to the DDR. Instead, many of these potentially harmful proteins contribute 
to proper telomere function: 
The MRX complex and Tel1, for example, both contribute to telomere length 
maintenance (Ritchie and Petes 2000). The Ku70/80 heterodimer, which as 
described above is recruited early to DSBs due to its affinity for exposed DNA ends, 
is involved in telomere capping (Fellerhoff, Eckardt-Schupp et al. 2000), while 
promoting NHEJ at DSBs. At telomeres Ku inhibits nuclease activities and thus helps 
prevent recombinational processes and checkpoint activation (Maringele and Lydall 
2002). 
1.6 Telomere attrition causes an irreversible cell cycle arrest called 
replicative senescence 
Apart from the end protection problem, telomeres also face the "end replication 
problem": Due to the inability of the canonical replication machinery to fully replicate 
a linear DNA molecule, telomeres shorten with each round of cell division. However, 
the loss of telomeric sequence is not exclusive to lagging telomere synthesis, which 
suffers the removal of the outermost RNA primer. The C-rich strand serving as a 
template for leading strand synthesis can be replicated to its end. The resulting blunt 
ended telomere needs to be processed to form the G-rich overhang required for 
proper telomere function (Lingner, Cooper et al. 1995, Soudet, Jolivet et al. 2014). 
The mechanistic problem of the end replication of the lagging telomere was first 
recognized and described by James Watson in 1972 (Watson 1972) and Alexei 
Olovnikov in 1973 (Olovnikov 1973). Experimental evidence for the relevance of this 
problem had already unknowingly been established by Leonard Hayflick in 1965 
(Hayflick 1965), who found that human diploid fibroblasts can only undergo a finite 
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number of cell divisions (the "Hayflick limit") when cultured in vitro. The irreversible 
cell cycle arrest triggered by telomere shortening due to cell division is termed 
replicative senescence. Replicative senescence is thought to be a powerful 
mechanism for tumour suppression and is likely also involved in aging (Lansdorp 
2008). 
In most human somatic cells telomeres shorten as cells divide. In human germ cells 
and, to a lesser extent, in human stem cells telomerase is expressed. Telomerase is 
a reverse transcriptase able to replenish chromosome ends with telomeric 
sequences using an associated non-coding RNA as a template (Greider and 
Blackburn 1985, Greider and Blackburn 1989). 
The S. cerevisiae telomerase consists of the catalytic subunit Est2, the RNA 
component encoded by TLC1 and the two regulatory subunits, Est1 and Est3 
(Lundblad and Szostak 1989, Lendvay, Morris et al. 1996). The Rap1-Rif1/2 
complexes suppress recruitment of telomerase through inhibition of MRX binding. As 
telomeres shorten, Rap1 binding sites become less abundant, allowing the 
sequential recruitment of the MRX complex and the Tel1 kinase (Ritchie and Petes 
2000, Tsukamoto, Taggart et al. 2001). This leads to extensive resection depending 
on Sae2, Sgs1, Dna2 and Exo1 (Dionne and Wellinger 1996). The ssDNA is bound 
predominantly by Cdc13, which in turn recruits Est1 and leads to the assembly of 
active telomerase, preferentially at short telomeres (Evans and Lundblad 1999, 
Teixeira, Arneric et al. 2004). 
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Figure 4 Replicative senescence in H. sapiens and S. cerevisiae. The lack of telomerase 
expression in human somatic cells and in est2 cells in budding yeast causes the loss of 
telomeric sequence with each cell division, which leads to permanent cell cycle arrest called 
replicative senescence. A small fraction of cells can overcome this replication barrier. Human 
tumours re-elongate their telomeres by reactivating telomerase or by homologous 
recombination (Alternative Lengthening of Telomeres, ALT). In analogy to the human ALT 
pathway S. cerevisiae cells can form survivors. In human germ cells and wt yeast cells 
telomere length is maintained by telomerase. The situation in human stem cells, which 
express telomerase to some extent, is not shown. 
In telomerase-deficient yeast cells, similar to telomerase-negative mammalian cells, 
telomeres progressively shorten and cells lose viability over many generations until 
they stop dividing and arrest at the G2/M border (Figure 4). This state termed "crisis" 
is characterized by the irreversible activation of DNA damage checkpoints due to 
eroded telomeres, which are no longer able to fulfil their protective function. Although 
it has been shown that the G2/M arrest due to telomere attrition depends on 
Mec1/Ddc2, Rad24, Ddc1/Mec3, Rad9 and Rad53, thus sharing similarities with the 
response to DNA damage, the signalling of eroded telomeres is not yet fully 
understood (Enomoto, Glowczewski et al. 2002, Ijpma and Greider 2003, Grandin, 
Bailly et al. 2005, Deshpande, Ivanova et al. 2011). Nevertheless, mounting evidence 
suggests that it is the length of the shortest telomere that is of particular importance 
in determining the onset of replicative senescence (Abdallah, Luciano et al. 2009, Xu 
2013). Moreover, telomere processing during replicative senescence also seems to 
be length dependent (Fallet, Jolivet et al. 2014). 
A small fraction of senescent cells is able to regain viability by re-elongating their 
telomeres based on a homologous recombination-dependent mechanism. These 
cells are called survivors (Lundblad and Blackburn 1993). They are generally thought 
to be the yeast equivalent of human ALT (alternative lengthening of telomeres) 
cancer cells. About 10-15 % of human tumours maintain their telomeres by this 
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telomerase-independent recombination-mediated mechanism (Cesare and Reddel 
2010). A comprehensive review highlighting the significance of budding yeast for the 
research on replicative senescence is (Teixeira 2013), which served as a basis for 
this section. 
1.7 RTT101 deletion has pleiotropic effects 
Rtt101 is a member of the cullin family of proteins. Cullins are defined by an 
evolutionarily conserved cullin homology domain and can be found in a wide variety 
of phylogenetic groups including chordates, nematodes and yeast (Kipreos, Lander 
et al. 1996, Mathias, Johnson et al. 1996). They act as molecular scaffolds facilitating 
the assembly of multi-subunit Cullin-RING ubiquitin E3 Ligase complexes (CRL). All 
cullin proteins possess a conserved C-terminal domain that binds the RING finger 
protein Hrt1/Roc1, which recruits an E2 ubiquitin-conjugating enzyme. Rtt101 
functions with the ubiquitin-conjugating enzyme Cdc34. The N-terminal domain of 
cullins is more diverse, thus allowing the interaction with a variety of different 
substrate-specific adaptor proteins (Michel, McCarville et al. 2003, Zaidi, Rabut et al. 
2008). 
The ubiquitination of a target protein requires the coordinated action of three distinct 
steps: The ATP-dependent activation of the ubiquitin molecule by an E1 activating 
enzyme is followed by the transfer of ubiquitin to an E2 ubiquitin-conjugating enzyme 
in a trans(thio)esterification reaction. An E3 ligase catalyses the formation of an 
isopeptide bond between the carboxy-terminal glycine residue of ubiquitin and the 
substrate lysine ε-amino group by bringing substrate and E2 ligase into close 
proximity. The result of target protein modification by a ubiquitin chain 
(polyubiquitination) depends on the chain structure. Ubiquitin contains seven lysine 
residues, which can themselves act as ubiquitin acceptors. Lys48-linked ubiquitin 
chains generally target substrate proteins for proteasomal degradation while Lys63-
linked chains have non-degradative roles and alter protein function (Sarikas, 
Hartmann et al. 2011). 
There are seven cullins in Homo sapiens (CUL1 to CUL3, CUL4A, CUL4B, CUL5 
and CUL7) and three cullins in Saccharomyces cerevisiae (Cdc53, Cul3 and Rtt101). 
Cdc53 is the only essential budding yeast cullin. It is thought to be the homologue of 
human CUL1. The Cdc53 assembled complex contains an F-box protein as 
substrate-specific adaptor, whose interaction with Cdc53 is mediated by Skp1. The 
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SCF (Skp1, Cullin, F-box) complex promotes the G1-S transition by targeting both 
G1 cyclins and the Clb-CDK inhibitor, Sic1 for degradation (Willems, Schwab et al. 
2004). 
Cul3 shares sequence similarities with human CUL3. It forms a complex with Elc1 
that polyubiquitinates monoubiquitinated RNA Pol II to trigger its proteasomal 
destruction after UV irradiation (Ribar, Prakash et al. 2007). 
Despite missing sequence similarity Rtt101 has been suggested to be the yeast 
equivalent of the human CUL4 subfamily since the Rtt101-interacting factor Mms1 
was identified as a distant homologue of the CUL4-interacting factor DDB1 (Zaidi, 
Rabut et al. 2008). Indeed, both Rtt101 and CUL4-assembled complexes have been 
shown to participate in genome maintenance mechanisms by regulating DNA 
replication and repair. 
Rtt101 (regulator of Ty1 transposition 101) was first identified as a suppressor of Ty1 
retrotransposon mobility (Scholes, Banerjee et al. 2001). Since then a wide variety of 
phenotypes have been described for cells lacking Rtt101, only some of which can be 
discussed here. 
rtt101 cells accumulate at the metaphase to anaphase transition (Michel, McCarville 
et al. 2003). This is likely due to the accumulation of spontaneous DNA damage 
occurring in S-phase since deletion of the damage checkpoint proteins Mec1 and 
Rad9 relieves the anaphase delay while deletion of the mitotic checkpoint protein 
Mad2 does not. The number of repair events as measured by Rad52-GFP and Ddc1-
GFP repair foci as well as gross chromosomal rearrangements (GCR), are indeed 
increased in unchallenged conditions in rtt101 cells compared to wt. A role for Rtt101 
during S-phase is further supported by the observation that replication fork 
progression through damaged and naturally difficult to replicate regions is impaired in 
rtt101 cells (Luke, Versini et al. 2006). The mechanism of how Rtt101 might relieve 
replisome blockage remains elusive. However, Rtt101 and its putative complex 
members Mms1 and Mms22 have been suggested to regulate HR-dependent 
processes in response to replication stress both in fission and budding yeast 
(Baldwin, Berger et al. 2005, Duro, Vaisica et al. 2008, Dovey, Aslanian et al. 2009, 
Vaisica, Baryshnikova et al. 2011, Vejrup-Hansen, Mizuno et al. 2011). 
Rtt101's role in S-phase is underlined by the fact that rtt101 cells display a striking 
hypersensitivity to the genotoxic agents MMS and CPT, which cause DNA damage 
that is exacerbated in S-phase and leads to replication stress by blocking replication 
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fork progression (Chang, Bellaoui et al. 2002, Laplaza, Bostick et al. 2004, Parsons, 
Brost et al. 2004, Luke, Versini et al. 2006). rtt101 cells are mildly hypersensitive to 
HU, which causes fork stalling due to nucleotide depletion, and show low sensitivity 
to ionising radiation and UV treatment (Michel, McCarville et al. 2003, Parsons, Brost 
et al. 2004, Luke, Versini et al. 2006, Kapitzky, Beltrao et al. 2010). While the 
checkpoint recovery of rtt101 cells after MMS treatment is severely delayed, 
checkpoint deactivation in response to HU occurs with normal kinetics (Luke, Versini 
et al. 2006). 
The sensitivity to MMS and CPT may in part be attributed to Rtt101's role in 
nucleosome assembly. Rtt101-dependent ubiquitination of H3 upon presentation of 
the acetylated H3-H4 heterodimer by the histone chaperone Asf1 allows H3-H4 
deposition onto newly replicated DNA by reducing its affinity to Asf1. This process is 
crucial for the establishment of a proper chromatin structure following replication, 
gene transcription and DNA damage repair. However, the deletion of RTT101 is 
additive with ubiquitination-deficient H3 mutants in terms of drug sensitivity (Han, 
Zhang et al. 2013) indicating that Rtt101-assembled complexes fulfil other functions 
important for the maintenance of genomic stability in addition to sustaining a proper 
chromatin structure. 
As described in section 1.3 (above) it has been shown that Rtt101 is recruited to 
chromatin as a consequence of DNA damage induced by MMS and that this 
recruitment depends on the presence of Rtt107 (Roberts, Zaidi et al. 2008). 
Moreover, genetic evidence suggests that Rtt107 does not play a role in the 
nucleosome assembly pathway described above (Pan, Ye et al. 2006, Collins, Miller 
et al. 2007). 
Five different putative substrate specific adaptor proteins have been shown to 
interact with Rtt101: the DNA repair and replication stress response protein Rtt107, 
the replication-associated repair protein Esc2, the replisome member Ctf4, the 
subunit of the origin recognition complex ORC5 and the regulator of RNR gene 
transcription and DDR protein Crt10. Their interaction with Rtt101 is bridged by the 
two linker proteins Mms1 and Mms22 (Figure 5A) (Zaidi, Rabut et al. 2008, Mimura, 
Yamaguchi et al. 2010). 
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Figure 5 Rtt101 assembles a variety of ubiquitin E3 ligase complexes (A) Rtt101 
interacts with its substrate specific adaptor proteins via the linker proteins Mms1 and Mms22. 
(B) Three target proteins have been identified whose ubiquitination depends on Rtt101. 
Mms22 seems to be both a linker and a target protein. The exact composition of the ligase 
complexes ubiquitinating H3 and Spt16 is not known. 
Nevertheless, only two bona fide targets have so far been identified apart from 
histone H3. One of them is Spt16, a member of the FACT complex. On the one hand, 
the FACT complex interacts directly with DNA polymerase α. On the other hand it is 
part of the replisome progression complex. Deletion of RTT101 reduces the 
association of Spt16 and MCM proteins with early replication origins and exacerbates 
the sensitivity of cells carrying the heat sensitive spt16-11 allele to replication stress. 
Han and co-workers conclude that Rtt101-dependent ubiquitination of Spt16 seems 
to target the FACT complex for replication instead of transcription (Han, Li et al. 
2010).  
The third confirmed target of Rtt101 is Mms22. Therefore Mms22 is not just a 
member of the ubiquitin E3 ligase complex Rtt101Mms1Mms22. It very likely also 
becomes its target after having been recruited to sites of DNA damage and having 
fulfilled its function there. What exactly this function is remains unclear. Nevertheless, 
the degradation of Mms22 seems to be necessary for yeast cells to re-enter the cell 
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cycle after G2/M arrest due to MMS-induced DNA damage (Ben-Aroya, Agmon et al. 
2010).  
The three identified Rtt101 targets indicate that Rtt101 plays a versatile role in 
replication (Spt16) and replication-associated processes, such as the response to 
replication-associated DNA damage (Mms22 and Spt16) and replication-coupled (as 
well as replication-independent) nucleosome assembly (histone H3-H4 heterodimer) 
in budding yeast. 
As mentioned above, Rtt101Mms1 has been proposed to be the counterpart of the 
human CUL4DDB1 complex due to the sequence similarity of MMS1 and DDB1 (Zaidi, 
Rabut et al. 2008). RTT101 shares no significant sequence homology with the two 
highly similar CUL4 genes, CUL4A and CUL4B, which seem to be functionally 
redundant. Just like Rtt101Mms1 in Saccharomyces cerevisiae, CUL4DDB1 promotes 
both replication-coupled and replication-independent nucleosome assembly by 
ubiquitinating histones H3.1 and H3.3, which affects their interaction with histone 
chaperones Asf1a/b, Daxx and HIRA (Han, Zhang et al. 2013). Nakagawa and Xiong 
could previously show that CUL4 regulates neuronal gene expression by degrading 
WDR5, a core component of the H3 lysine 4 methyltransferase (Nakagawa and 
Xiong 2011). 
CUL4DDB1 also contributes in several ways to the complex balance of factors 
promoting and suppressing replication in an unperturbed S-phase as well as in the 
face of DNA damage. In cooperation with PCNA, CUL4DDB1 targets CDK inhibitor p21 
for degradation after irradiation with low doses of UV (Abbas, Sivaprasad et al. 
2008). In a similar mechanism the replication factor Cdt1 is degraded in a CUL4DDB1- 
and PCNA-dependent manner (Higa, Mihaylov et al. 2003, Hu, McCall et al. 2004, 
Senga, Sivaprasad et al. 2006), a pathway also identified in fission yeast (Ralph, 
Boye et al. 2006). Thus, human CUL4-based ubiquitin-ligase complexes have been 
shown to regulate chromatin dynamics and contribute to the maintenance of genome 
integrity during S-phase. Some of the uncovered pathways seem to be conserved 
from yeast to human. 
In budding yeast, two reports connect Rtt101 to telomere biology. First, rtt101 cells 
were shown to be desilenced in the subtelomeric region, suggesting a role for Rtt101 
in the maintenance of the telomere position effect (Mimura, Yamaguchi et al. 2010). 
Whether this is due to the defective chromatin structure of rtt101 cells has not yet 
been addressed. Second, a genome-wide screen from the Lydall laboratory identified 
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RTT101 as one of about 200 genes, many of which implicated in DNA damage 
repair, whose deletion accelerated entry of telomerase-deficient cells into replicative 
senescence (Chang, Lawless et al. 2011). 
1.8 Aims of this study 
The known targets of Rtt101-assembled ubiquitin E3 ligase complexes are not able 
to explain the phenotypes associated with RTT101 deletion. Especially, one of the 
most striking phenotypes of rtt101 cells, their hypersensitivity to certain genotoxic 
agents and the role of Rtt101 during S-phase are far from being understood. In this 
study we aimed to identify potential targets of Rtt101-assembled ubiquitin E3 ligase 
complexes involved in the cellular response to DNA damage and replication stress. 
The second aim of this study was to elucidate Rtt101's role in preventing premature 
senescence. The biology and maintenance of telomeres is closely connected to the 
field of DNA damage and repair due to the structural similarity of telomeres with 
DSBs. Replicative senescence is a natural process that highlights the intimate 
relation between telomeres and damage as short telomeres provoke a cellular 
response resembling the DDR. As described, telomeres, in particular short 
telomeres, are difficult to replicate regions of the genome. This allows the speculation 
that Rtt101's role during telomere-induced senescence might resemble its role in the 
response to DNA damage and replication stress. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Yeast strains 
The yeast strains used in this study were derived from BY4741 background (his3-1, 
leu2-0, ura3-0, met15-0). 
Code Genotype 
YBL7 Wt 
YBL1306 MATα rtt101::NAT 
YBL61 MATa rtt101::KAN 
YLK297 MATα rtt101::NAT 
YLK419 MATα mms1::NAT 
YLK288 MATa mms22::NAT 
YLK410 MATα ctf4::NAT 
YMD1500 MATa esc2::NAT 
YMD1364 MATa mrc1::KAN 
YMD1348 MATa pol32::KAN 
YMD1353 MATa rad27::KAN 
YMD1355 MATa top1::KAN 
YMD1359 MATa dpb4::KAN 
YMD1354 MATa siz2::KAN 
YMD1362 MATa met7::KAN 
YMD1461 MATα rtt101::NAT mrc1::KAN 
YMD1388 MATa rtt101::NAT pol32::KAN 
YMD1400 MATa rtt101::NAT rad27::KAN 
YMD1412 MATa rtt101::NAT top1::KAN 
YMD1424 MATα rtt101::NAT dpb4::KAN 
YMD1368 MATa rtt101::NAT siz2::KAN 
YMD1445 MATα rtt101::NAT met7::KAN 
YLK495 MATa mms1::NAT mrc1::KAN 
YLK432 MATa mms1::NAT pol32::KAN 
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Code Genotype 
YLK434 MATa mms1::NAT rad27::KAN 
YLK437 MATa mms1::NAT top1::KAN 
YLK435 MATa mms1::NAT dpb4::KAN 
YLK430 MATa mms1::NAT siz2::KAN 
YMD1579 MATα mms22::NAT mrc1::KAN 
YMD1485 MATα mms22::NAT pol32::KAN 
YMD1489 MATa mms22::NAT rad27::KAN 
YMD1497 MATa mms22::NAT top1::KAN 
YMD1473 MATa mms22::NAT dpb4::KAN 
YMD1493 MATα mms22::NAT siz2::KAN 
YMD1477 MATα mms22::NAT met7::KAN 
YLK422 MATa ctf4::NAT pol32::KAN 
YLK424 MATa ctf4::NAT top1::KAN 
YLK426 MATa ctf4::NAT dpb4::KAN 
YLK420 MATa ctf4::NAT siz2::KAN 
YMD1522 MATa esc2::NAT mrc1::KAN 
YMD1506 MATα esc2::NAT pol32::KAN 
YMD1530 MATα esc2::NAT rad27::KAN 
YMD1518 MATa esc2::NAT top1::KAN 
YMD1514 MATa esc2::NAT dpb4::KAN 
YMD1510 MATα esc2::NAT siz2::KAN 
YMD1526 MATa esc2::NAT met7::KAN 
YMD1636 MATa rad27::KAN 
YMD1637 MATα rad27::KAN mrc1::NAT 
YMD1600 MATa ubc13::KAN 
YMD1601 MATα ubc13::KAN mrc1::NAT 
YMD1624 MATα csm3::KAN 
YMD1625 MATa csm3::KAN rtt101::NAT 
YMD1614 MATa tof1::KAN 
YMD1615 MATα tof1::KAN rtt101::NAT 
YLK490 MATa bar1::HIS3 
YLK470 MATa bar1::HIS3 rtt101::NAT 
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Code Genotype 
YLK473 MATa bar1::HIS3 mrc1::KAN 
YLK478 MATa bar1::HIS3 rtt101::NAT mrc1::KAN 
YMD1655 MATa bar1::NAT MRC1-TAP-HIS3 
YMD1657 MATa bar1::NAT MRC1-TAP-HIS3 rtt101::KAN 
YMD1658 MATa bar1::NAT MRC1-TAP-HIS3 dia2::HYG 
YLK492 MATa/MATα RTT101/rtt101::NAT MRC1/mrc1::KAN 
DIA2/dia2::HYG 
YVK91 MATa/MATα RTT101/rtt101::HYG MRC1/mrc1::KAN 
RAD52/rad52::NAT 
YLK268 MATa/MATα  RTT101/rtt101::KAN EST2/est2::HIS3 
YLK379 MATa/MATα MMS1/mms1::KAN EST2/est2::HIS3 
YLK359 MATa/MATα MMS22/mms22::KAN EST2/est2::HIS3 
YLK345 MATa/MATα ESC2/esc2::KAN EST2/est2::HIS3 
YLK347 MATa/MATα CTF4/ctf4::KAN EST2/ est2::HIS3 
YLK331 MATa/MATα CRT10/crt10::KAN EST2/est2::HIS3 
YLK362 MATa/MATα ORC5/orc5-70-KAN EST2/est2::HIS3 
YLK329 MATa/MATα RTT101/rtt101::KAN RAD52/rad52::NAT 
EST2/ est2::HIS3 
YLK439 MATa/MATα RTT101/rtt101::NAT MRC1/mrc1::KAN 
EST2/ est2::HIS3 
 
2.1.2 Plasmids 
Code Plasmid 
pLK16 mrc1-aq.kanMX4 in pRS426 
pLK18 mrc1-aq.HIS3 in pRS426 
pLK20 pRS415 LEU2 
pLK23 MRC1 genomic locus in pRS415 
pLK26 mrc11-971 in pRS415 
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2.1.3 Oligonucleotides 
Code Name Sequence (5´-3´) Exp. 
oBL358 1L 
GCG GTA CCA GGG TTA GAT TAG 
GGC TG 
telomere PCR 
oBL359 oligo-dG CGG GAT CC(G)18 telomere PCR 
oBL361 6Y´ TTA GGG CTA TGT AGA AGT GCT G telomere PCR 
oBL207 TERRA 
CAC CAC ACC CAC ACA CCA CAC 
CCA CA 
southern blot 
oBK295 1L-fwd 
CGG TGG GTG AGT GGT AGT AAG 
TAG A 
ChIP 
oBL296 1L-rev ACC CTG TCC CAT TCA ACC ATA C ChIP 
oLK57 15L-fwd GGG TAA CGA GTG GGG AGG TAA ChIP 
oLK58 15L-rev 
CAA CAC TAC CCT AAT CTA ACC CTG 
T 
ChIP 
oLK49 6Y´-fwd GGC TTG GAG GAG ACG TAC ATG ChIP 
oLK50 6Y´-rev CTC GCT GTC ACT CCT TAC CCG ChIP 
oAM47 rDNA-fwd TCC AAT TGT TCC TCG TTA AG ChIP 
oAM48 rDNA-rev ATT CAG GGA GGT AGT GAC AA ChIP 
 
2.1.4 Antibodies 
Antibody Source 
Rad53 EL7.E1 Marco Foiani 
Mrc1-TAP Sigma Aldrich 
Pgk1 Life technologies 
S9.6 antibody David Tollervey 
Goat Anti-Mouse-HRP Conjugate BioRad 
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2.1.5 Liquid media and plates 
Plates YPD 
YPD Agar 65 g 
ddH20 1 L 
Autoclave 20 min 65 °C 
 
For YPD plates containing antibiotics add: 
100 µg/mL for NAT (Nourseothricin or G418), 250 µg/mL for KAN (Kanamycin), and 
300 µg/mL for HYG (Hygromycin B) 
 
Plates SD complete SD - AA 
Yeast synthetic dropout Medium 
supplement without amino acids 
1.92 g 1.92 g 
Yeast nitrogen base without amino 
acids 
6.7 g 6.7 g 
Agar 24 g 24 g 
100 x AA 10 mL - 
dd H2O 960 mL 960 mL 
Autoclave 20 min 65 °C 20 min 65 °C 
50 % glucose (final conc. 2 %) 40 mL 40 mL 
 
Plates Pre-Sporulation  Plates 
Standard nutrient broth 12 g 
Yeast extract 4 g 
Agar 8 g 
dd H2O 360 mL 
Autoclave 20 min 65 °C 
50 % Glucose 40 mL 
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Liquid medium LB 
Yeast extract 5 g 
Trypton 10 g 
NaCl 10 g 
dd H2O 1 L 
Autoclave 20 min 65 °C 
 
For LB medium containing Carbanicillin add 1 mL of Carbanicillin at a concentration 
of 100 ng/mL. 
 
Plates LB 
LB agar 200 g 
dd H2O 5 L 
Autocave 20 min 65 °C 
 
For LB plates containing Ampicillin add 100 µg/mL Ampicillin. 
 
Liquid medium SOC 
Trypton 20 g 
Yeast extract 5 g 
NaCl 0.5 g 
KCl 0.186 g 
Glucose 3.6 g 
Adjust pH with 5 M NaOH about 200 µL 
dd H2O 1 L 
Autoclave 20 min 65 °C 
Before use add 2 M MgCl2 (prepared of 
1 M MgCl26 H2O and 1 M MgSO47 H2O 
5 mL 
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2.1.6 Buffers 
10 x TE  
TRIS (1 M, pH 7.5) 400 mL 
EDTA (0.5 M) 80 mL 
H2O 3520 mL 
Autoclave 20 min 65 °C 
 
10 x TBE  
TRIS 108 g 
0.5 M EDTA (set to pH 8 with NaOH) 20 mL 
Boric Acid 55 g 
dd H2O 1 L 
Autoclave 20 min 110 °C 
 
20 x SSC  
NaCl 175.3 g 
Sodium citrate 88.2 g 
Adjust to pH 7 HCl 
dd H2O 1 L 
Autoclave 20 min 65 °C 
 
10 x PBS  
NaCl 80 g 
KCl 2 g 
Na2HPO4 x 7 H2O 26.8 g 
KH2PO4 2.4 g 
Adjust to pH 7.4 HCl 
dd H2O 1 L 
Autoclave 20 min 65 °C 
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LiAc Mix  
1 M Lithium Acetate (sterile) 10 mL 
10 x TE (sterile) 10 mL 
Sterile dd H2O 80 mL 
 
AE buffer  
Natrium acetate anhydrous 2.05 g 
EDTA 1.46 g 
Sterile dd H2O 500 mL 
Adjust to pH 5.3 NaOH 
Autoclave 20 min 65 °C 
 
SDS 10 % SDS 20 % SDS 
SDS 20 g 40 g 
Sterile dd H2O 200 mL 200 mL 
Sterilization  Millipore filter 0.22 µm Millipore filter 0.22 µm 
 
Hybridization solution  
Formamide 50 mL 
20 x SSC 25 mL 
50 x Denhardt's solution 10 mL 
0.5 M EDTA 1 mL 
PIPES 1 M (pH 6.4) 1 mL 
Yeast RNA 40 mg in 3 mL H2O heat to 65 °C and filter sterilize 
10 % SDS 10 mL 
Sterilize Heat to 65 °C and use Millipore filter 0.22 µm 
 
PIPES 1M pH 6.4  
PIPES 30.2 g 
dd H2O 100 mL 
Adjust to pH 6.4 NaOH 
Autoclave 20 min 65 °C 
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5 x DIG wash buffer  
Maleic acid 58 g 
Adjust pH to 7.5 NaOH 
NaCl 43.8 g 
Tween-20 15 mL 
dd H2O 1 L 
Autoclave 20 min 65 °C 
 
Maleic acid buffer  
Maleic acid 11.67 g 
Adjust to pH 7.5 NaOH 
NaCl 8.76 g 
dd H2O 1 L 
Autoclave 20 min 65 °C 
 
DIG detection buffer  
Tris-HCl 15.8 g 
NaCl 5.8 g 
dd H2O 1 L 
Adjust to pH 9.5 HCl 
Autoclave 20 min 65 °C 
 
10 x blocking solution  
Blocking solution powder 10 g 
Maleic acid buffer 100 mL 
dd H2O 100 mL 
 
1 x blocking solution   
10 x blocking solution 3 mL 
Maleic acid buffer 27 mL 
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Denaturing solution  
NaOH 16 g 
NaCl 35.1 g 
dd H2O 1 L 
 
Neutralizing solution  
NaCl 52.6 g 
Trizma -Base 36.3 g 
dd H2O 1 L 
Adjust to pH 7.5  
 
10 x Telomere PCR buffer  
Tris-HCl (pH 8.8) 810 mg 
(NH4)2SO4 211 mg 
70 % glycerol 7.1 mg 
Tween-20 (0.1 %) 10 µL 
dd H2O 10 mL 
 
Elution buffer B  
Tris-HCl pH 7.5 50 mM 
SDS 1 % 
EDTA pH8.0 10 mM 
dd H2O 250 mL 
 
FA lysis buffer -SOD +SOD 
HEPES-KOH pH 7.5 50 mM 50 mM 
NaCl 140 mM 140 mM  
EDTA pH 8.0 1 mM 1 mM  
Triton X-100 1 % 1 % 
Sodium deoxycholate - 0.1 % 
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FA lysis buffer 500  
HEPES-KOH pH 7.5 50 mM 
NaCl 500 mM 
EDTA pH 8.0 1 mM 
Triton X-100 1 % 
Sodium deoxycholate 0.1 % 
 
Buffer III  
Tris-HCl pH 8.0 10 mM 
EDTA pH 8.0 1 mM 
LiCl 250 mM 
NP-40 1 % 
Sodium deoxycholate 1 % 
 
Urea loading buffer  
Tris-HCl pH 8.8 1.2 mL (1 M) 
5 % glycerol final 714 µL (70 %) 
8 M urea final 4.8 g 
143 mM β-mercaptoethanol final 100 µL (14.3 M) 
8 % SDS final 4 mL (20 %) 
dd H2O 10 mL 
Add bromophenol blue to colour the buffer  
Tris-HCl pH 6.8 1.2 mL 
 
Solution 1  
NaOH (10 M) 3.7 mL 
dd H2O 14.78 mL 
β-mercaptoethanol 1.52 mL 
 
Solution 2  
TCA 100 % 10 mL 
dd H2O 10 mL 
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Solution 3  
Acetone 100 % 
 
2.1.7 Other materials 
Enzymes Company 
DNase and DNase buffer New England Biolabs 
Phusion Polymerase New England Biolabs 
Proteinase K Qiagen 
RNase A Applichem 
Terminal Transferase New England Biolabs 
Restriction enzymes New England Biolabs 
 
Ladders Company 
1 kb DNA ladder New England Biolabs 
100 bp DNA ladder New England Biolabs 
DIG-labelled molecular weight marker Roche 
 
Kits Company 
Puregene Yeast/Bact. Kit B Qiagen 
Qiaquick Gel Extraction Kit  Qiagen 
Qiaquick PCR purification Kit  Qiagen 
Zero Blunt TOPO PCR cloning Kit for Sequencing Invitrogen 
DirectPrep 96 MiniPrep 3' End labeling Kit 2nd generation Roche 
DyNAmo Flash SYBR Green qPCR Kit Thermo Scientific 
 
Additional Materials Company 
α-factor ZymoResearch 
Bradford solution AppliChem 
Bromophenol blue indicator Sigma Aldrich 
Camptothecin (CPT) Sigma Aldrich 
CDP-Star Roche 
Denhardt's solution (50x) AppliChem 
 43 
Materials and Methods 
 
  
Additional Materials Company 
dNTPs New England Biolabs 
Hydroxyurea (HU) Sigma Aldrich 
Lysing Matrix C tubes MP Biomedicals 
Methylmethane sulfonate (MMS) Sigma Aldrich 
Mini Protean TGX Precast Gels BioRad 
Nylon Membrane (positively charged) GE Healthcare 
One Shot DH5α TM-T1 E. coli Invitrogen 
Protease inhibitor mix complete Mini 
tablet EDTA-free 
Roche 
Protein A Sepharose 4 Fast Flow beads GE Healthcare 
Transblot nitrocellulose membrane BioRad 
Zeocin Invitrogen 
2.1.8 Electronic devices and software 
Electronic devices Company 
Bioraptor Twin XD10 Diagenode 
Blotting apparatus Trans-Blot Turbo BioRad 
Dissecting Microscope MSM manual Singer Instruments 
Dot blot apparatus BioRad 
Hybridization oven MS incubator Uniequip GmbH 
Incubators MIR154 Sanyo 
LAS 4000 FujiFilm 
Light Cycler 480 Roche 
Microscope with 40 x objective Optech Technology 
Nanodrop 2000C Thermo Scientific 
Photometer Ultraspec 3100pro Amersham Biosciences 
Thermocycler C1000 BioRad 
UV Stratalinker 2400 Stratagene 
 
Software Company 
Adobe Illustrator Adobe 
Adobe Photoshop Adobe 
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Software Company 
End Note Thomson Reuters 
Excel Microsoft 
FileMaker Pro FileMaker Inc. 
ImageJ Wayne Rasband (NIH) 
MultiGauge FujiFilm 
Prism Graph Pad 
Sequencher Gene codes Corporation 
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2.2 Methods 
2.2.1 High-throughput screen 
A high-throughput screen was carried out as described in (Buser, Kellner et al.): 
Synthetic Genetic Array (SGA) methodology was used as first reported by Tong and 
colleagues (Tong, Evangelista et al. 2001). The procedure was modified in the 
following way: A non-essential heterozygous diploid S. cerevisiae knockout 
collection, kindly provided by M. Knop, was sporulated and crossed to an rtt101::NAT 
can1::STE2pr-SpHis5 strain (Y7092, C. Boone). Diploid cells were selected by 
repinning on YPD plates containing 100 µg/mL nourseothricin and 250 µg/mL of the 
kanamycin analogue G418. Diploids were then induced to sporulate. Haploid double 
mutants were selected by repinning on MATa selection plates (SD-his/arg/lys + 
canavanine + thiolysine) followed by a repinning on MATa selection plates containing 
100 µg/mL nourseothricin and 250 µg/mL of the kanamycin analogue G418. Colonies 
were then repinned onto SD complete, SD + 0.01 % MMS and SD + 5 µM CPT. After 
24 h incubation at 30 °C cells were repinned onto the same media, incubated at 
30 °C and repinned again after 24 h. Pictures of the last repinning taken after 24 h 
incubation at 30 °C are shown in Figure 6. Double mutants that showed increased 
resistance to either MMS or CPT were classified as suppressors. Scoring of the 
suppressors was done by hand. Validation was carried out by manually crossing and 
dissecting tetrads from independent starter strains and subsequent duplicate spot 
assays onto drug containing media. 
2.2.2 Transformation of S. cerevisiae 
25 mL of exponentially growing yeast cells (OD600 0.4 - 0.8) were centrifuged at 
3000 rpm for 5 min at RT, washed once in 5 mL LiAc mix and centrifuged again at 
3000 rpm. The supernatant was removed and the pellet resuspended in 250 µL LiAc 
mix. 100 µL of cells were used per transformation and mixed with 500 ng of plasmid 
DNA, 10 µL of single-stranded carrier DNA (Yeastmaker Carrier DNA, Clontech) and 
700 µL of PEG mix and incubated 30 min at RT. Cells were heat shocked for 15 min 
at 42 °C, pelleted at 3000 rpm and resuspended in 300 µL YPD. Cells were 
incubated in YPD for 30 min at 30 °C and spread on the appropriate selection plate 
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with sterile glass beads. The selection plates were incubated for 2-3 days before 
successfully transformed colonies were picked and restreaked on selective media. 
2.2.3 Genomic DNA extraction from S. cerevisiae 
Genomic DNA was extracted from S. cerevisiae using the Puregene Yeast/Bact. 
Kit B from Qiagen. DNA sample concentrations were measured with the nanodrop 
ND-1000 Spectrophotometer. 
2.2.4 Spotting assay 
Yeast cells were incubated overnight at 30 °C in appropriate medium. The cultures 
were diluted to OD600 0.5 and spotted in ten-fold serial dilutions. 5 µL of each dilution 
were spotted. The plates were incubated at 30 °C for 3 days and imaged using the 
LAS4000 (Fujifilm) after 2 and 3 days of incubation. 
2.2.5 Yeast protein extraction, SDS-PAGE and western blotting 
Appropriate amounts of exponentially growing cells were harvested by centrifugation 
of culture volumes corresponding to 2 OD600 units (13000 rpm for 2 min at RT). Cell 
pellets were stored at -20 °C if necessary. Cells were resuspended in 150 µL of 
Solution 1 (0.97 M β-mercaptoethanol, 1.8 M NaOH) and incubated on ice for 10 min 
before 150 µL of Solution 2 (50 % TCA) were added and cells were again incubated 
10 min on ice. Cells were pelleted (13000 rpm for 2 min at 4 °C) and subsequently 
resuspended in 1 mL acetone. The samples were centrifuged again (13000 rpm for 
2 min at 4 °C) and the pellets resuspended in 100 µL urea buffer (120 mM Tris-HCl 
pH 6.8, 5 % glycerol, 8 M urea, 143 mM 2-mercaptoethanol, 8 % SDS, bromophenol 
blue indicator). Protein extracts were incubated 5 min at 55 °C and centrifuged 
(8000 rpm for 30 sec at RT) before they were loaded onto Mini-PROTEAN Precast 
Gels (BioRad) (7.5 % for detection of Rad53, 4-15 % gradient gels for detection of 
Mrc1-TAP, Actin and Pgk1). The following antibodies were used: Rad53 (EL7.E1, gift 
from Marco Foiani) at 1:16, Mrc1-TAP (Sigma Aldrich P1291) at 1:200, Actin (Merck 
Millipore MAB1501) at 1:1000, Pgk1 (Life technologies, 22C5D8) at 1:25000. 
Proteins were detected using the Super Signal West Pico Chemiluminescent 
Substrate (Thermo Scientific) and the LAS4000 (Fujifilm). 
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2.2.6 Analysis of DNA content by Fluorescence-Activated Cell Sorting (FACS) 
In order to collect appropriate amounts of exponentially growing cells, 0.68 OD600 
units of cell cultures were spun down (3000 rpm for 5 min at RT). Cell pellets were 
resuspended in 1 mL cold 70 % ethanol and stored at 4  C. Prior to an RNase A 
treatment (3 h at 37 °C with 10 µL of 10 mg/mL RNase A) cells were washed in 1 mL 
H2O (3000 rpm for 5 min at RT) and resuspended in 0.5 mL 50 mM Tris-HCl (pH 8.0). 
Following the RNase A treatment cells were collected by centrifugation (3000 rpm for 
5 min at RT), resuspended in 0.5 mL 50 mM Tris-HCl (pH 7.5) containing 1 mg/mL 
Proteinase K and incubated for 45 min at 50 °C. After centrifugation (3000 rpm for 
5 min at RT) cells were resuspended in 0.5 mL 50 mM Tris-HCl (pH 7.5). 100 µL of 
cells were used for sonication (five consecutive rounds of sonication, 15 sec each, 
using the Bioruptor Twin XD10 set to low intensity). 50 µL of cells were mixed with 
1 mL of 1 x SYTOX Green (Life Technologies) in 50 mM Tris-HCl (pH 7.5) to stain 
DNA. Cells were kept dark and the DNA content was analysed immediately using a 
BD FACSCanto II flow cytometer with the following filters and settings: FSC and SSC 
were detected with a 488 nm laser with detector settings of 318 V and 360 V, 
respectively. SYTOX Green was detected with a 502 nm longpass filter and 
530/30 nm bandpass filter at 466 V. 20000 events per sample were analysed in each 
run. BD FACSDiva software was used for data collection and FlowJo v10.0.6 
(Miltenyi Biotec) software was used for data analysis. 
2.2.7 MMS-induced checkpoint arrest and recovery experiment 
20 mL of exponentially growing yeast cells (bar1 MATa) at OD600 0.6 were arrested 
in G1 with α-factor (2 µM final concentration) for 2.5 h. To verify efficient arrest 
shmooing of the cultures was checked using an Optech Technology light microscope. 
Cells were washed in 40 mL YPD pre-warmed at 30°C (3000 rpm for 2 min at 25 °C). 
Cells were resuspended in 25 mL of pre-warmed YPD and samples were taken for 
OD measurement, protein extraction and FACS. Cultures were incubated with MMS 
(final concentration of 0.01 %) at 30 °C shaking (230 rpm) for 60 min. Cells were 
collected by centrifugation (3000 rpm for 2 min at 25 °C) and resuspended in 6 mL 
pre-warmed YPD containing sodium thiosulfate (2.5 % w/v final concentration) to 
quench MMS. Cells were collected by centrifugation (3000 rpm for 2 min at 25 °C) 
and resuspended in an appropriate volume of pre-warmed YPD to keep cells in 
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exponential phase for the following 60 min (OD600 ~ 0.8). Samples were taken for OD 
measurement, protein extraction and FACS. 
At four more time points spaced at 60 min intervals samples were taken for OD 
measurement, protein extraction and FACS during recovery from MMS-induced 
checkpoint arrest. At each time point the volume of each culture was adjusted with 
pre-warmed YPD to ensure continued growth in exponential phase. 
2.2.8 Protein stability measurement by cyclohexamide chase during recovery 
from MMS-induced checkpoint arrest 
The experiment was performed as described above with the following modifications: 
After α-factor arrest cells were released into prewarmed YPD containing MMS at a 
final concentration of 0.03 % and incubated for 45 min. After MMS quenching and 
wash-out cyclohexamide (CHX) was added to each culture to a final concentration of 
200 µg/mL to inhibit protein biosynthesis. After CHX addition samples for protein 
extraction were taken every 30 min. 
2.2.9 Senescence assay 
Spore colonies of freshly dissected heterozygous diploids were diluted in 5 mL YPD 
to a final concentration of OD600 0.01. Cells were incubated for 24 h at 30 °C and the 
optical density of each culture was measured at 600 nm. Cultures were then re-
diluted to OD600 0.01 and incubated for further 24 h at 30 °C. The remaining culture 
was pelleted and pellets were frozen at -20 °C for further analysis (telomere PCR and 
Southern blotting). Senescence curves are displayed as the average relative cell 
density plotted against the average population doublings of all cultures of the same 
genotype. Population doublings (PD) were calculated as log2 (OD600
24h/0.01). PD 
values refer to population doublings after the spore had grown on the dissection plate 
for 2-3 days depending on the growth rate, which corresponds to about 25 population 
doublings. The relative cell density was calculated by arbitrarily setting the OD600 of 
day 1 to 100 % for each culture. Graphs were made using GraphPad Prism Version 
5.0d. Differences in the mean values of relative cell densities of different genotypes 
were tested for statistical significance using the Mann Whitney test. The test was 
carried out in GraphPad Prism Version 5.0d. One star indicates a p-value ≤ 0.05, two 
stars indicate a p-value ≤ 0.01 and three stars indicate a p-value ≤ 0.001. 
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2.2.10 Telomere length measurement by telomere PCR 
Telomere PCR was performed using 100 ng of genomic DNA (Puregene Yeast/Bact. 
Kit B, Qiagen) in 9 µL 1 x NEB4 buffer. Samples were denatured for 10 min at 96 °C 
and cooled to 4 °C using the Thermal Cycler (Bio-Rad). For the C-tailing reaction 
1 µL of 10 x tailing mix (40 U/µL terminal transferase in 10 x NEB4 buffer and 10 mM 
dCTPs) was added and samples were incubated for 30 min at 37 °C, 10 min at 
65 °C, 5 min at 96 °C before they were cooled to 65 °C. 30 µL of preheated PCR-Mix 
containing 1 µM oligo dG reverse primer, 1 µM telomere-specific forward primer, 
0.267 mM dNTPs, 0.083 U/µL Phusion polymerase (NEB) in PCR buffer (89.11 mM 
Tris-HCl pH 8.8, 21.28 mM (NH4)2SO4, 6.65 % glycerol, 0.0133 % Tween-20) were 
added and the PCR reaction performed using the following protocol: 3 min at 95 °C, 
45 cycles (30 s at 95 °C, 15 s at 63 °C, 20 s at 72 °C), 5 min at 72 °C, hold on 12 °C. 
Samples were separated on a 1.8 % agarose gel containing 0.005 % RedSafe at 
100 V for 25 min. Bands were detected using the LAS4000 (Fujifilm) and telomere 
length analysed using the Multi Gauge Software (Fujifilm). 
2.2.11 Telomere length measurement by Southern blot analysis of terminal 
restriction fragment lengths 
Genomic DNA was extracted from cell pellets (Puregene Yeast/Bact. Kit B, Qiagen), 
which had been collected during the course of the senescence assay as described 
above. 20 µg of genomic DNA were digested with 2 µL of XhoI restriction enzyme at 
37 °C overnight in a final volume of 50 µL. 2 µL of each digested sample were 
separated on a 1.2 % agarose gel containing 0.005 % RedSafe at 100 V for 30 min 
and bands were quantified using ImageJ. 15 µg of digested DNA were loaded onto a 
1.2 % agarose gel containing 0.005 % RedSafe and run at 100 V for 15 min and at 
25 V overnight. An image of the gel was taken using the LAS4000 (Fujifilm). The 
DNA was transferred onto a positively charged nylon membrane at 1 Amp for 2 h in 
0.5 x TBE at 4 °C. The membrane was rinsed in 2 x SSC before the DNA was 
crosslinked to the membrane using the UV Stratalinker 2400. The DNA was then 
denatured by washing the membrane in denaturing solution for 1 h followed by two 
10 min washes in neutralizing solution. Following, the membrane was incubated with 
pre-warmed hybridization solution at 47.5 °C for 1 h. 7.5 µL of DIG labelled probe 
(oBL207) diluted in 5 mL hybridization solution were denatured at 95 °C for 5 min and 
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subsequently cooled on ice. For hybridization the membrane was incubated with the 
denatured, diluted probe at 47.5 °C overnight. Detection was performed as described 
by the product guidelines of the Roche DIG oligonucleotide 3'-End labelling KIT using 
the LAS4000 for chemiluminescence detection. 
2.2.12 Telomere cloning and sequencing 
Telomere cloning and sequencing was carried out as reported in (Chang, Dittmar et 
al. 2011). QIAquick PCR Purification Kit (Qiagen) was used to purify telomere PCR 
products. The purified DNA was cloned into a pCR4Blunt-TOPO vector using the 
Zero Blunt TOPO PCR Cloning Kit for Sequencing, which was used to transform One 
Shot DH5αTM-T1 E. coli cells. DNA from transformed clones was isolated using the 
DirectPrep 96 MiniPrep Kit (Qiagen) and analysed with Sequencher software. 
2.2.13 Chromatin immunoprecipitation (ChIP) 
Crosslinking: Cells were grown to exponential phase at 30 °C in YPD and diluted to 
OD600 0.74 in 50 mL YPD. Crosslinking was performed by the addition of 
formaldehyde to a final concentration of 1.2 % for 10 min at RT to the shaking 
cultures. The crosslinking reaction was quenched by the addition of glycine to a final 
concentration of 360 mM while cultures were shaking for 5 more minutes at RT. The 
cells were then put on ice for 5 min, pelleted and washed twice in cold PBS by 
spinning for 4 min at 3000 rpm at 4 °C. Cell pellets were stored at -80 °C. 
Cell lysis: Cells were resuspended in 200 µL cold FA lysis buffer - SOD  and lysed at 
4 °C in lysing Matrix C tubes using the FastPrep machine at 6.5 M/s for two times 
30 sec with 1 min on ice between runs. Cell extracts were recovered by the addition 
of 800 µL FA Lysis buffer + SOD and pelleted by centrifugation at 13000 rpm for 
7 min at 4 °C in fresh Eppendorf tubes. The soluble portion of the lysate was 
discarded and pellets were resuspended in 1.5 mL FA Lysis buffer + SOD containing 
0.26 % SDS and split into three 500 µL for sonication. 
Sonication: Chromatin was sheared at 4 °C using the Bioruptor Twin XD10 in 
13 cycles with each cycle consisting of 30 sec shearing at high intensity followed by a 
30 sec break. Samples were centrifuged for 15 min at 15000 rpm at 4 °C. The 
supernatant is referred to as the ChIP extract. Protein concentration of the ChIP 
extract was determined by Bradford assay and the ChIP extract diluted to a protein 
concentration of 1 mg/mL. To verify the sonication efficiency 100 µL of ChIP extract 
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were incubated overnight at 65 °C and treated with 7.5 µL of Proteinase K for 2 h at 
37 °C. The DNA was purified with QIAquick PCR purification Kit (Qiagen), treated 
with RNase A solution (Quiagen) for 30 min at 37 °C and analysed by gel 
electrophoresis on a 1.5 % agarose gel. Efficient sonication results in a bulk fragment 
size between 100 and 500 bp. 
Preclearing and IP: Two times 1 mL of the diluted ChIP extract of each sample was 
pre-cleared by the addition of 20 µL of protein A sepharose beads for 1 h at 4 °C. 
The beads had previously been washed with 1 x PBS, incubated with 1 x BSA for 1 h 
at 4 °C, washed again in 1 x PBS and resuspended in 1 x FA lysis buffer + SOD. 
After the pre-clearing step RNA-DNA hybrids were precipitated by incubating the 
samples overnight at 4 °C rotating with 35 μl of 1 x PBS-washed protein A sepharose 
beads in the presence or absence of a mouse monoclonal S9.6 antibody at a final 
concentration of 32 μg/mL. 
Washes and Elution: The beads were then successively washed in FA lysis 
buffer + SOD, in FA lysis buffer 500, in 1 x FA buffer III and in 1 x TE (pH 8.0). Each 
washing step was carried out in 1 mL of liquid at 4 °C rotating for 5 min followed by 
centrifugation at 3000 rpm for 2 min at 4 °C. The supernatant was removed and the 
precipitated DNA was eluted from the beads by the addition of 100 µL of Elution 
buffer B for 8 min at 65 °C. The elution step was repeated with the same volume of 
elution buffer and the final volume of 200 µL was stored at -80 °C. 
Reverse crosslinking and purification: The samples were incubated at 65 °C 
overnight with 7.5  µL of Proteinase K for protein digestion. The remaining DNA was 
cleaned with the QIAquick PCR Purification Kit, eluted in 50 µL of water and stored at 
-20°C. 
Quantification by qPCR: Telomeric RNA-DNA hybrid levels were measured by qPCR 
using the LightCycler480 and the DyNAmo Flash SYBR Green qPCR Kit using the 
following protocol (10 min at 95 °C for denaturing followed by 40 cycles of 15 sec at 
95 °C, 1 min at 60 °C). The final primer concentrations were: 1L (1 µM), 15L 
(100 nM), Y' (300 nM) and rDNA (500 nM). The input values in percent were 
calculated as 100*2 [adjusted input - Ct (IP)]. The adjusted input was calculated as Ct (input) 
- log2(20) to account for the fact that the input fraction is 5 % (dilution factor of 20, 
which corresponds to log2(20) = 4.322 cycles). 
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3 Results 
3.1 The ubiquitin E3 ligase Rtt101 affects the replication stress 
response through Mrc1/Claspin 
3.1.1 A genetic screen for mutations suppressing the rtt101 drug sensitivity 
reveals potential targets of Rtt101-assembled ubiquitin E3 ligase 
complexes 
In order to identify novel targets of Rtt101, which are ubiquitinated in the response to 
DNA damage or the ensuing replication stress, we used a genetic approach. We 
reasoned that in the absence of Rtt101 a variety of its targets would accumulate in 
their de-ubiquitinated form causing a disturbed or deregulated DNA damage 
response (DDR) that leads to the striking hypersensitivity of rtt101 cells to genotoxic 
agents. Thus, combined deletion of RTT101 and the gene encoding the potential 
target protein might relieve the rtt101 drug sensitivity (Figure 6B). Therefore, we 
designed a screen, pairwise combining the deletion of RTT101 with the deletion of 
about 4800 non-essential genes in Saccharomyces cerevisiae and testing the 
resulting double mutants for growth on MMS and CPT. As described in section 2.2.1 
(above), MMS and CPT cause replication stress that ultimately leads to DSBs and 
other DNA lesions: Synthetic Genetic Array (SGA) methodology was used (Tong, 
Evangelista et al. 2001) to cross the rtt101 mutation to a non-essential knockout 
collection (kindly provided by M. Knop). The resulting haploid double mutants were 
pinned onto SD plates containing either 0.01 % MMS or 5 μM CPT (Figure 6C and 
D). The occurrence of suppressors, i.e. double mutants that showed increased 
resistance to either MMS or CPT, was scored manually using pictures of the plates 
taken after appropriate incubation time. For a more detailed description of the drug 
sensitivity screen the reader is referred to the "Materials and Methods" section. 
Validation by manually crossing and dissecting tetrads from independent starter 
strains followed by duplicate spot assays onto drug containing media confirmed 16 of 
24 candidates yielded by the screen to be true suppressor mutations of rtt101 drug 
sensitivity (Figure 6F).  
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Figure 6 Screen for suppressors of rtt101 hypersensitivity to MMS and CPT (A) rtt101, 
mms1 and mms22 cells are hypersensitive to MMS, CPT, HU and Zeocin (B) Rationale of 
screen design: combined deletion of RTT101 and a potential target, whose accumulation 
inhibits DDR, might relieve rtt101 drug sensitivity (C) Simplified schematic view of SGA 
procedure (D) Representative examples of pinning plates (E) Confirmation spottings of seven 
out of 16 confirmed suppressors (F) List of the 16 confirmed suppressors. Screen and 
spottings were performed by Martina Dees. 
 54 
Results 
 
  
In our further analysis we concentrated on those genes that (i) showed strong or 
intermediate suppression of rtt101 drug sensitivity or (ii) had previously been 
implicated in replication or repair (Figure 6E). These genes encoded the following 
proteins: 
The S-phase checkpoint and replication protein Mrc1, the DNA polymerase δ subunit 
Pol32, the 5' flap endonuclease Rad27, Topoisomerase I (Top1), the DNA 
polymerase ε subunit Dpb4, the SUMO E3 ligase Siz2 and the Folylpolyglutamate 
synthetase Met7. 
It is conceivable that the different suppressor proteins affect a number of different 
pathways required to cope with DNA damage or replicative stress. Nevertheless, it is 
noteworthy that both Mrc1 and Dpb4 are connected to the leading strand polymerase 
Pol ԑ and their deletion was able to relieve the growth defect of rtt101 cells on both 
MMS and CPT, with the deletion of MRC1 resulting in the most striking effect. 
Deletion of POL32, RAD27 and TOP1 conferred resistance to CPT only. 
The results of the screen suggest that Mrc1, Pol32, Rad27, Top1, Dpb4, Siz2 and 
Met7 are potential targets of Rtt101-assembled ubiquitin E3 ligase complexes and 
that their accumulation in the de-ubiquitinated form impairs a proper DDR or 
replication stress response, either because their destruction by the ubiquitin-
proteasome system or alteration of their function by ubiquitination is necessary to 
allow the appropriate cellular reaction to lesions caused by MMS and CPT. 
3.1.2 Rtt101' s function in response to MMS and CPT relies almost fully on 
Mms1 and Mms22 
Rtt101 has been shown to assemble a variety of protein complexes (Collins, Miller et 
al. 2007, Zaidi, Rabut et al. 2008, Han, Li et al. 2010, Mimura, Yamaguchi et al. 
2010, Han, Zhang et al. 2013). The C-terminus of Rtt101 recruits the E2 ubiquitin-
conjugating enzyme Cdc34 via the bridging protein Hrt1 (Michel, McCarville et al. 
2003). The N-terminus of Rtt101 binds Mms1, which resembles human DDB1 and 
recruits a number of substrate specific adaptor proteins either directly or via the 
bridging factor Mms22 (Zaidi, Rabut et al. 2008, Mimura, Yamaguchi et al. 2010). It 
has, however, also been suggested that Rtt101 can bind at least one of its 
substrates, Spt16, a member of the FACT complex, in the absence of both Mms1 
and Mms22 (Han, Li et al. 2010). 
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Table 1 Overview of the effect of selected suppressor mutations on the sensitivity of 
rtt101, mms1, mms22, ctf4 and esc2 cells to MMS, CPT, HU and Zeocin 
Therefore we wanted to explore whether those mutations able to suppress the drug 
sensitivity of rtt101 cells were also able to suppress the drug sensitivity of mms1 and 
mms22 cells.  
Like rtt101 cells, both mms1 and mms22 are hypersensitive to MMS and CPT 
(Figure 6A). While the hypersensitivities of mms1 and rtt101 to MMS and CPT seems 
to be identical, mms22 shows more severe sensitivity to MMS and CPT than rtt101 
(Figure 6A). Hypersensitivity of mms1 and mms22 cells to both MMS and CPT are 
epistatic with that of rtt101 (Zaidi, Rabut et al. 2008). This suggests that Rtt101's role 
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in the response to DNA damage is shared by Mms1, and that Mms22's role in the 
DDR partially overlaps with, but also exceeds that of Rtt101. 
The suppressor mutations alleviating rtt101 drug sensitivity to MMS and CPT also 
alleviated mms1 and mms22 drug sensitivity, with two exceptions: the deletion of 
RAD27 did not reduce the hypersensitivity of mms22 cells to CPT and deletion of 
DPB4 only slightly reduced the hypersensitivity of mms22 cells to MMS. MET7 was 
excluded from the analysis because the met7 strain showed extremely variable 
growth on YPD. The results of the spotting assays are summarized in Table 1. For 
the original spotting assays the reader is referred to Supplemental Figure 1 to 5.  
The results of these spottings suggest that the functions of Rtt101 in response to 
lesions induced by MMS and CPT rely fully on the presence of Mms1 and in most 
instances also on Mms22, while also comprising elements independent of Mms22. In 
the presence of the genotoxic agents MMS and CPT, Mrc1, Pol32, Rad27, Dpb4 and 
Siz2 seem to cause toxic intermediates, whose abrogation in the majority of cases 
requires the concerted action of Rtt101, Mms1 and Mms22. 
3.1.3 Mutations alleviating rtt101 drug sensitivity to MMS and CPT are specific 
and do not alleviate rtt101 drug sensitivity to HU or Zeocin 
Next, we wanted to determine whether the suppressor mutations identified in our 
screen also relieved drug sensitivity of rtt101, mms1 and mms22 cells to HU and 
Zeocin (Table 1). None of the suppressor mutations was able to increase the 
resistance of rtt101, mms1 or mms22 cells to either HU or Zeocin with the exception 
of the deletion of MRC1, which relieved the hypersensitivity of mms22 cells to both 
HU and Zeocin. 
Hypersensitivity of rtt101 and mms1 cells is particularly severe for lesions induced by 
MMS and CPT, indicating that Rtt101 and Mms1 contribute substantially to the 
cellular response to these lesions. By contrast, hypersensitivity of rtt101 and mms1 to 
HU is mild, suggesting that the cellular response to HU relies on mechanisms 
different from those required in response to MMS and CPT. Thus, it is not surprising 
that the mutations alleviating rtt101 and mms1 drug sensitivity to MMS and CPT are 
specific and do not alleviate rtt101 and mms1 drug sensitivity to HU or Zeocin. 
The role of Mms22 in response to DNA damage and replication stress seems to be 
more general than that of Rtt101 and Mms1 and intimately connected to Mrc1. 
Hypersensitivity of mms22 cells to MMS, CPT, HU and Zeocin exceeds that of rtt101 
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and mms1 cells and is alleviated by MRC1 deletion for all four drugs. This is in 
agreement with other studies in yeast and human cells suggesting that Mms22 
promotes HR-dependent repair processes independent of Rtt101Mms1, which might 
contribute to damage repair or fork restart (Baldwin, Berger et al. 2005, Duro, Lundin 
et al. 2010, O'Donnell, Panier et al. 2010). 
Some of our spottings on HU and Zeocin were inconclusive due to varying results or 
inappropriate drug concentrations. For these cases, it is at this moment not possible 
to evaluate the effect of the double deletion mutant concludingly. 
3.1.4 ctf4 and esc2 cells both show major differences and commonalities 
compared to rtt101 cells in terms of their drug sensitivity and its 
suppression 
Telomere shortening is a particular type of DNA damage that elicits a response that 
in many ways resembles that induced by genomic lesions (reviewed in (Dewar and 
Lydall 2012)). Interestingly, Rtt101 seems to contribute to the maintenance of both 
shortening telomeres during senescence (Chang, Lawless et al. 2011)(and S. Luke-
Glaser personal communication) and telomeric chromatin of wt length telomeres 
(Mimura, Yamaguchi et al. 2010).  
Esc2 is a protein implicated in replication-associated recombination, sister chromatid 
cohesion and silencing. Ctf4 is part of the replisome and also required for sister 
chromatid cohesion. Esc2 and Ctf4 have been reported to interact with Rtt101 via 
Mms1 or via Mms1 and Mms22 respectively (Mimura, Yamaguchi et al. 2010) and 
share the premature senescence observed in rtt101 cells (this study, Figure 14). This 
could indicate that they also share or contribute to Rtt101's role in response to MMS- 
and CPT-induced lesions. In this case we would expect that the suppressors of rtt101 
drug sensitivity also alleviate drug sensitivity of esc2 and ctf4. The results of our 
spottings are summarized in Table 1. The original spottings are shown in 
Supplemental Figure 4 and Supplemental Figure 5. 
ctf4 cells show both major differences and commonalities compared to rtt101 cells in 
terms of their drug sensitivity and its suppression. rtt101 cells show severe 
hypersensitivity to MMS and CPT and mild hypersensitivity to HU and Zeocin. ctf4 
cells are highly sensitive to all four genotoxic agents. Deletion of TOP1, DPB4 and 
SIZ2 alleviated the sensitivity of rtt101 and ctf4 cells to CPT, indicating that Ctf4 
might act in concert with Rtt101, e. g by recruiting the common suppressors for 
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subsequent ubiquitination. Interestingly, the deletion of MRC1, which results in the 
most striking alleviation of rtt101 sensitivity to both MMS and CPT, results in 
synthetic lethality of ctf4 cells. This result has been published before (Tong, Lesage 
et al. 2004). The double mutant is inviable due to replication defects that cause 
permanent checkpoint activation and prevent successful genome duplication 
(Gambus, van Deursen et al. 2009). A recent study by Luciano and colleagues 
(Luciano, Dehé et al. 2015) sheds light on the relationship between Ctf4, Mrc1 and 
an Rtt101-comprising pathway during replicative stress. They show that the deletion 
of either CTF4 or MRC1 is beneficial for CPT-treated asf1 cells. Since Rtt101 acts 
downstream of the histone chaperone Asf1 they speculate that Ctf4 and Mrc1 might 
be targets of Rtt101. This is in agreement with our results and will be discussed in 
more detail in section 4.2 (Discussion). 
esc2 cells are mildly hypersensitive only to MMS and Zeocin. Thus, Esc2 does not 
seem to be a member of the Rtt101-based complexes assembled in response to 
CPT and HU. Nevertheless, Esc2 might contribute to the recruitment of Mrc1 and 
Dpb4 since deletion of these proteins alleviated the hypersensitivity of both esc2 and 
rtt101 cells to MMS (Table 1). 
Thus our spottings give clear indications, which of the Rtt101-mediated pathways in 
response to DNA damage might rely on Ctf4 or Esc2. Further experiments are 
necessary to test the suggested interactions. 
 
 
Figure 7 Suppression of drug sensitivity by MRC1 deletion is specific to the Rtt101-
mediated pathway of the DDR: MRC1 deletion does not rescue the sensitivity of ubc13 
cells to MMS. Spottings were performed by Martina Dees. 
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3.1.5 The suppression of MMS hypersensitivity by MRC1 deletion is specific to 
the Rtt101-mediated pathway of the DDR 
Having explored the effects of a selection of suppressors of rtt101 drug sensitivity on 
putative Rtt101 complex members, we set out to uncover the mechanistic details of 
the suppression of rtt101 drug sensitivity by the deletion of MRC1 since it conferred 
the most striking effect on both MMS and CPT. 
Mrc1 is a mediator of the replication checkpoint and activates Rad53 in response to 
replication stress (Alcasabas, Osborn et al. 2001, Tanaka and Russell 2001). It also 
forms part of the replisome and is required for normal replication progression (Szyjka, 
Viggiani et al. 2005, Tourriere, Versini et al. 2005, Hodgson, Calzada et al. 2007), in 
particular due to its role in coupling the CMG helicase to Polԑ (Lou, Komata et al. 
2008, Komata, Bando et al. 2009). Together with Tof1 and Csm3, Mrc1 forms a 
replication fork pausing complex that stabilizes the replication fork during replication 
stress (Katou, Kanoh et al. 2003).  
The DNA methylating agent MMS and the Topoisomerase I inhibitor CPT create 
replication obstacles, which cause fork stalling that can lead to the formation of DSBs 
(Pommier 2006, Wyatt and Pittman 2006) We wondered whether the alleviation of 
drug sensitivity by the deletion of MRC1 was indeed specific to cells sensitized to 
DNA damage by the deletion of RTT101, or whether other MMS hypersensitive 
mutants were also rescued. 
Ubc13 is an E2 ubiquitin-conjugating enzyme involved in post-replicative repair 
(Brusky, Zhu et al. 2000), whose deletion sensitizes cells to MMS. It forms a 
heteromeric complex with Mms2 and interacts physically with the chromatin-
associated RING-finger proteins Rad18 and Rad6. Our spottings in Figure 7 show 
that MMS sensitivity of ubc13 cells is not reduced but slightly aggravated by MRC1 
deletion. 
Rad52 is the pivotal protein of the S. cerevisiae recombination machinery. It 
promotes the exchange of the abundant ssDNA binding protein RPA for the Rad51 
recombinase and catalyses the DNA annealing step in recombination processes 
(Mortensen, Lisby et al. 2009). Since many repair pathways rely on recombinational 
processes rad52 cells are particularly sensitive to a wide range of DNA damaging 
agents including MMS. MRC1 deletion aggravates the hypersensitivity of rad52 cells 
to MMS (Figure 7). 
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These results indicate that deletion of MRC1 does not generally relieve 
hypersensitivity to MMS for example by a generally dampened checkpoint response 
that could allow a variety of DNA repair deficient mutants to continue cell cycle 
progression despite unrepaired lesions. Instead, the alleviation of hypersensitivity to 
MMS by MRC1 deletion seems to be characteristic for those genome maintenance 
mechanisms that rely on Rtt101. 
 
Figure 8 Deletions of CSM3 of TOF1 do not alleviate drug sensitivity of rtt101 cells. 
Spottings were performed by Martina Dees. 
3.1.6 Deletions of CSM3 or TOF1 do not alleviate drug sensitivity of rtt101 
cells 
Mrc1, Csm3 and Tof1 form a heterotrimeric complex that associates with replication 
forks and is required for normal replication fork progression. It stabilizes stalled forks 
and promotes sister chromatid cohesion repair after DNA damage (Katou, Kanoh et 
al. 2003, Bando, Katou et al. 2009). Like Mrc1, Tof1 contributes to Rad53 
phosphorylation in response to replication stress, albeit to a lesser extent (Foss 
2001). Since Mrc1's functions partially overlap with those of Tof1 and Csm3 we 
asked whether their deletion might also impact on the drug sensitivity of rtt101 cells. 
This is not the case as our spottings in Figure 8 show. 
Our results point to a unique function of Mrc1. This could be Mrc1's role in signalling 
replication stress, its crucial role in replisome stabilization and coupling, the unique 
combination of these two or a so far uncharacterized function of Mrc1. 
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Figure 9 Loss of Mrc1 checkpoint function is not sufficient for the suppression of 
rtt101 drug sensitivity (A) The Mrc1-AQ mutant is unable to relieve the hypersensitivity of 
rtt101 cells to MMS. (B) The Mrc11-971 alleviates the hypersensitivity of rtt101 cells to MMS. 
Spottings were performed by Martina Dees. 
3.1.7 Loss of Mrc1 checkpoint function is not sufficient for the suppression of 
rtt101 drug sensitivity 
Two separation-of-function alleles of Mrc1 have been described and characterized in 
detail: the mrc1-AQ allele and the mrc11-971 allele. Both have been described as 
checkpoint-defective and replication-proficient (Osborn and Elledge 2003, Fong, 
Arumugam et al. 2013). In order to gain a better understanding of the mechanism 
underlying the suppression of rtt101 drug sensitivity by MRC1 deletion we analysed 
the effect of both alleles on the MMS sensitivity of rtt101 cells. 
The Mrc1-AQ mutant, in which all Mec1-targeted S/TQ phosphosites are mutated to 
AQ, was unable to relieve the hypersensitivity of rtt101 cells to MMS (Figure 9A). 
Surprisingly, the Mrc11-971 mutant, which lacks the last 125 amino acids, did indeed 
phenocopy the alleviation of drug sensitivity, which was seen with the full deletion of 
Mrc1 (Figure 9B). These results clearly indicate that the loss of Mrc1's checkpoint 
function is not sufficient to rescue rtt101 drug sensitivity. Instead, our experiments 
suggest that Mrc1’s C-terminus is toxic for cells under replicative stress lacking 
Rtt101. 
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Figure 10 MRC1 deletion allows timely checkpoint downregulation during recovery 
from MMS-induced damage. (A) Schematic overview of the experiment: cells in exp. phase 
were arrested in G1 by the addition of α-factor (2 μM final concentration). Arrested cells were 
released into YPD containing 0.01 % MMS and released into YPD after 1 h for recovery. At 
the indicated points in time samples were taken for protein extraction and FACS (B) Western 
blots with anti Rad53 antibody for the indicated genotypes. In all strains BAR1 was deleted 
for efficient α -factor arrest. As reported previously rtt101 cells show prolonged checkpoint 
activation as measured by the upshift of the Rad53 band due to Rad53 phosphorylation. 
MRC1 deletion allows rtt101 cells to downregulate their checkpoint during recovery from 
MMS-induced damage. (C) FACS profiles show that rtt101 mrc1 cells re-enter the cell cycle 
in a manner comparable to mrc1 cells. 
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Mrc1 interacts directly with Pol2 via two independent binding sites situated in Mrc1’s 
N- and C-terminal domain respectively (Lou, Komata et al. 2008). The mrc11-971 
mutant strain goes through S-phase normally in unchallenged conditions (Fong, 
Arumugam et al. 2013). Our results allow the conclusion that Mrc1’s C-terminal 
interaction with Pol2 might be specifically counteracted by Rtt101 in the face of DNA 
damage-induced replicative stress. 
3.1.8 MRC1 deletion allows timely checkpoint downregulation during recovery 
from MMS-induced damage 
One of several phenotypes described for rtt101 cells is their prolonged checkpoint 
activation in response to treatment with MMS (Luke, Versini et al. 2006). Prolonged 
checkpoint activation could be due (i) to a defective checkpoint downregulation after 
termination of cellular repair activities or (ii) to prolonged persistence of damage due 
to a defective damage response. 
We decided to test the effect of combined deletion of RTT101 and MRC1 on the 
checkpoint activation during recovery from MMS treatment by monitoring the 
phosphorylation status of Rad53. Therefore, cells were synchronised by the addition 
of α-factor, released into MMS and allowed to recover from MMS treatment for four 
hours (Figure 10A). 
Deletion of MRC1 did indeed allow rtt101 cells to dephosphorylate Rad53 in a 
manner comparable to wt after release from MMS-induced stress (Figure 10B). 
FACS profiles showed that rtt101 mrc1 cells were also able to re-enter the cell cycle 
more efficiently than rtt101 cells and in a manner comparable to mrc1 cells, though 
less efficiently than wt (Figure 10C). 
Interestingly, in our experiment mrc1 cells activated and deactivated the checkpoint 
with kinetics similar to wt cells. This is in agreement with the fact that the deletion of 
MRC1 did not alleviate the MMS hypersensitivity of ubc13 cells, since both results 
indicate that lack of Mrc1 does not generally hamper the checkpoint activation in 
response to MMS. 
However, our result does not exclude the possibility that checkpoint downregulation 
following recovery from MMS-induced damage is defective in rtt101 cells due to the 
prolonged persistence of Mrc1. Indeed, it has been shown that degradation of Mrc1 
is required for checkpoint deactivation during recovery from MMS-induced damage. 
Mrc1 degradation partially depends on SCFDia2, a ubiquitin E3 ligase complex 
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assembled by the cullin Cdc53 (Mimura, Komata et al. 2009, Fong, Arumugam et al. 
2013). Therefore, we decided to test if Rtt101 contributes to Mrc1 degradation. 
 
Figure 11 Rtt101 and Dia2 contribute to recovery from MMS-induced damage through 
Mrc1 by two independent pathways. (A) Combined deletion of RTT101 and DIA2 leads to 
additive sensitivity to MMS. Hypersensitivity of both single mutants and the double mutant 
can be rescued by the deletion of MRC1. Spottings were performed by Vanessa Kellner (B) 
Schematic overview of the cycloheximide chase experiment to determine the stability of Mrc1 
during recovery from MMS-induced DNA damage. Cells in exponential phase were arrested 
in G1 by the addition of α-factor (2 μM final concentration). Arrested cells were released into 
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YPD containing 0.03 % MMS. After 45 min cells were released into YPD containing 
cycloheximide to inhibit protein synthesis during recovery from MMS. Samples for protein 
extraction were taken at the indicated time points. (C) Western blots with anti-TAP antibody 
for the indicated genotypes. In all strains BAR1 was deleted for efficient α-factor arrest. Pgk1 
serves as a loading control. (D) Quantification of western blot signals in (C): As reported 
previously, Mrc1 is degraded in wt cells during recovery from MMS and Mrc1 degradation 
depends partially on Dia2. Mrc1 is stabilized in rtt101 cells but absolute Mrc1 levels are lower 
than in wt. Western blots and their quantification were performed by Martina Dees. 
3.1.9 Rtt101 and SCFDia2 contribute to the recovery from MMS-induced damage 
through Mrc1 by two different pathways 
In order to explore whether Rtt101 mediates the degradation of Mrc1 to allow cell 
cycle resumption after MMS-induced stress in a pathway parallel to SCFDia2 we 
tested the sensitivity of rtt101, dia2 and rtt101 dia2 cells to MMS. Combined deletion 
of RTT101 and DIA2 did indeed lead to additive sensitivity to MMS. The 
hypersensitivity of both single mutants and the double mutant could be rescued by 
MRC1 deletion (Figure 11A). 
To test the effect of RTT101 deletion on the stability of Mrc1 during recovery from 
MMS-induced damage cells were synchronised by the addition of α-factor, released 
into MMS and allowed to recover from MMS treatment in the presence of 
cyclohexamide for two hours (Figure 11B). As reported by Fong and colleagues, 
Mrc1 is degraded in wt cells, but stabilized in the absence of Dia2. In rtt101 cells 
Mrc1 also seems to be stabilized. However, the absolute quantification of Mrc1 
protein levels showed that Mrc1 levels are extremely low in the absence of Rtt101, 
rendering a role of Rtt101 in Mrc1 degradation unlikely (Figure 11C and D). Since the 
results of this experiment were variable, MRC1 was placed under the control of a 
Gal-inducible promoter. Promoter shut-off experiments carried out by Vanessa 
Kellner could reproducibly show that Rtt101 does not affect Mrc1 degradation rates 
(data not shown but published in Buser, Kellner et al. 2016, see appendix 7.2). 
The results of the checkpoint recovery experiments described in Figure 10 and 
Figure 11 indicate that both Rtt101 and Dia2 contribute to the resumption of cell cycle 
progression after MMS-induced damage through Mrc1. Dia2 contributes to the 
dephosphorylation of Rad53 by Mrc1 degradation. Accordingly, hypersensitivity of 
dia2 cells to MMS is rescued by MRC1 deletion as well as by both checkpoint 
defective mrc1 alleles, mrc1-AQ and mrc11-971 (Fong, Arumugam et al. 2013).  
Prolonged checkpoint activation of rtt101 cells in response to MMS is rescued by 
MRC1 deletion. Hypersensitivity of rtt101 cells to MMS is rescued by MRC1 deletion 
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and by the mrc11-971 allele, but not by the mrc1-AQ allele. This indicates that the 
prolonged Rad53 phosphorylation is due to prolonged persistence of damage rather 
than to a defective checkpoint downregulation after successful repair.  
This is in agreement with the fact that rtt101 cells show increased levels of Rad52 
foci, which likely reflect repair activities (Luke, Versini et al. 2006). rtt101, mms1 and 
mms22 cells have also been reported to be deficient in Rad52-dependent repair 
mechanisms involved in the repair of MMS-induced damage and stalled RFs in both 
fission and budding yeast (Baldwin, Berger et al. 2005, Duro, Vaisica et al. 2008, 
Vejrup-Hansen, Mizuno et al. 2011). Therefore we decided to investigate the role of 
Rad52 for rtt101 drug sensitivity and its suppression by MRC1 deletion. 
 
Figure 12 For rtt101 and mms1 cells the suppression of hypersensitivity to MMS by 
MRC1 deletion depends on the presence of a Rad52. Spottings were performed by 
Vanessa Kellner. 
 67 
Results 
 
  
3.1.10 The suppression of rtt101 hypersensitivity to MMS by the deletion of 
MRC1 depends on a functional recombination machinery 
The Rad52 protein is central to virtually all homologous recombination pathways in 
S. cerevisiae. It promotes the exchange of RPA for Rad51 recombinase at ssDNA 
and catalyses the DNA annealing step in recombination processes (Mortensen, Lisby 
et al. 2009). Our spottings show that the suppression of rtt101 MMS hypersensitivity 
by MRC1 deletion depends on the presence of RAD52 (Figure 12A compare lines 6, 
7 and 8 of the plate containing 0.0025 % MMS). This is also true for mms1 cells 
(Figure 12B compare lines 14, 15 and 16 of the plate containing 0.0025 % MMS). 
Interestingly, mms22 cells are still rescued to a certain degree by MRC1 deletion in 
the absence of Rad52 (Figure 12C compare lines 22, 23 and 24 of the plate 
containing 0.00125 % MMS). This means that the rescue of mms22 cells by MRC1 
deletion is partially independent of HR processes. 
We conclude that the Rtt101Mms1Mms22 ubiquitin E3 ligase promotes the repair or 
restart of stalled RFs by a Rad52-dependent mechanism, which probably requires 
prior ubiquitination of Mrc1 (or an unknown factor regulating Mrc1) by the 
Rtt101Mms1Mms22 complex. Whether Mrc1 is degraded as a result of this process 
cannot be concluded at the moment. While our results suggest that Mrc1 stability is 
not affected by Rtt101, proteolysis of Mrc1 might take place at a small subset of 
stalled replication forks that is not reflected in global Mrc1 levels.  
In the absence of Mms22, MRC1 deletion leads to a partial rescue of MMS sensitivity 
even without a functional HR machinery. This indicates that Mms22 also promotes 
HR-independent pathways in response to genotoxic stress. This function of Mms22 
seems to be independent of Rtt101. Notwithstanding, both the HR-dependent and -
independent mechanisms appear to proceed only in the absence of the fork 
protection protein Mrc1 or require its prior modification.  
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3.2 The ubiquitin E3 ligase Rtt101 affects replicative senescence 
through Mrc1/Claspin 
3.2.1 Rtt101, Mms1 and Mms22 promote the viability of cells in the presence 
of short telomeres 
The ends of linear chromosomes resemble DSBs and must therefore be protected 
from the DNA damage response. Telomeres are nucleoprotein structures that protect 
and maintain chromosome ends. Telomere shortening due to the absence of 
telomerase leads to a gradual loss of the protective properties of telomeres. 
Interestingly, Rtt101 is not just required for the proper cellular response to several 
forms of DNA damage as induced by MMS and CPT, which lead to replication stress. 
Cells lacking Rtt101 also show accelerated senescence ((Chang, Lawless et al. 
2011) and S. Luke-Glaser, personal communication), suggesting that Rtt101 
promotes viability of cells in the presence of short telomeres, which represent a DNA 
damage-like structure. Having explored some aspects of Rtt101's role during 
replication stress induced by DNA damage, we decided to investigate Rtt101's role in 
replicative senescence. 
Despite the fact that wt yeast cells do not senesce, S. cerevisiae has been used for 
several decades as a valuable model organism to study replicative senescence 
(reviewed in (Teixeira 2013)). The EST2 gene encodes the catalytic subunit of the 
telomerase reverse transcriptase. TLC1 encodes the telomerase RNA moiety that 
serves as a template for telomere elongation. Deletion of either of these two genes 
leads to replicative senescence of budding yeast cells. 
As shown in Figure 13, rtt101 est2 cells senesced faster than est2 cells. While the 
viability of rtt101 est2 cells was identical to the viability of est2 cells for about 40 
population doublings (PDs), rtt101 est2 cells showed a dramatic loss of viability 
approximately during population doublings 40 to 70 and a particularly severe crisis 
(compare the lowest viabilities of rtt101 est2 and est2 cells). rtt101 est2 cells then 
formed survivors with kinetics and viability similar to est2 cells. 
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Figure 13 rtt101 est2, mms1 est2 and mms22 tlc1 cells senesce prematurely. (A-C) 
Senescence curves showing the accelerated senescence of rtt101 est2, mms1 est2 and 
mms22 tlc1 cells compared to est2 and tlc1 cells respectively. Each dot represents the mean 
of n cultures, with n = 6 for rtt101 est2 and mms22 tlc1 and n = 10 for mms1 est2. Error bars 
represent s.e.m. Statistical testing was performed using the Mann-Whitney test. p-values of 
p ≤ 0.05, p ≤ 0.01 and p ≤ 0.001 are represented by one, two and three stars respectively. 
(D) Simple model of the role of Rtt101 during replicative senescence. 
This could indicate that the action of Rtt101 is required particularly when telomeres 
become critically short and most resemble DNA damage, while Rtt101 seems to be 
dispensable during early population doublings and for survivor formation. 
Rtt101 serves as a platform for the assembly of multi-subunit ubiquitin E3 ligase 
complexes. The recruitment of target proteins seems to depend on the presence of 
Mms1 in most cases. Mms1 recruits a variety of substrate specific adaptor proteins 
either directly of via the bridging factor Mms22 (Collins, Miller et al. 2007, Zaidi, 
Rabut et al. 2008, Han, Li et al. 2010, Mimura, Yamaguchi et al. 2010, Han, Zhang et 
al. 2013). 
We wandered whether Mms1 and Mms22 shared the premature senescence 
phenotype just described for rtt101 est2 cells with the aim of identifying the complex 
members involved in the Rtt101-dependent pathway required to prevent premature 
senescence. The senescence curve in Figure 13B shows that the senescence of 
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mms1 est2 cells resembles that of rtt101 est2 cells strikingly: mms1 est2 cells 
senesced at the same rate as est2 cells during early population doublings, then 
underwent a dramatic loss of viability and severe crisis before forming survivors with 
kinetics and viability similar to est2 cells. 
Since the genomic loci of the MMS22 and the EST2 genes are located right next to 
each other it was not possible to retrieve the mms22 est2 double mutant by tetrad 
dissection. Therefore we made use of the mms22 tlc1 mutant. In comparison to 
rtt101 est2, the premature senescence phenotype of mms22 tlc1 cells started at 
earlier population doublings and survivor formation was slower than in tlc1 control 
cells (Figure 13C). 
We conclude that Mms1 is most likely part of the Rtt101-assembled ubiquitin E3 
ligase complex that is active during replicative senescence. Just like in the case of 
DNA damage sensitivity, the phenotype of mms22 cells is more severe than that of 
rtt101 cells during senescence. Thus Mms22 might well be a member of the Rtt101 
complex during senescence, but its functions clearly exceed those of Rtt101. 
Epistasis analysis by comparing replicative senescence of rtt101 mms22 tlc1 cells to 
rtt101 tlc1 cells and mms22 tlc1 cells within the same senescence curve was 
unsuccessful (data not shown). 
3.2.2 The two putative substrate-specific adaptors Esc2 and Ctf4 senesce 
prematurely 
The DNA repair and replication stress response protein Rtt107, the replication-
associated repair protein Esc2, the replisome member Ctf4, the subunit of the origin 
recognition complex ORC5 and the regulator of RNR gene transcription and DDR 
protein Crt10 have been identified as putative members of Rtt101-assembled 
complexes and could function as substrate specific adaptors recruiting substrates 
that remain to be determined. Their interaction with Rtt101 depends on the presence 
of Mms1 and in the case of Rtt107 and Ctf4 also on the presence of Mms22 as linker 
proteins bridging the interaction to Rtt101 as shown in Figure 5A (Zaidi, Rabut et al. 
2008, Mimura, Yamaguchi et al. 2010). We wandered, which of these proteins 
shared the premature senescence phenotype of rtt101 est2 cells and performed the 
corresponding senescence curves. 
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Figure 14 Two out of five putative members of Rtt101-assembled complexes share the 
premature senescence phenotype of rtt101 cells. (A-E) Senescence curves for esc2 est2, 
ctf4 est2, crt10 est2, rtt107 est2 and orc5-70 est2 cells respectively compared to est2 cells. 
Each dot represents the mean of n cultures, with n = 5 or n = 4 for all senescence curves 
displayed in this figure. Error bars represent s.e.m. Statistical testing was performed using 
the Mann-Whitney test. p-values of p ≤ 0.05, p ≤ 0.01 and p ≤ 0.001 are represented by one, 
two and three stars respectively. 
As the results displayed in Figure 14 show, only esc2 est2 and ctf4 est2 cells showed 
premature or aggravated senescence compared to est2 cells. Small differences 
between crt10 est2 and rtt107 est2 cells and their respective controls are not 
significant as assessed by the Mann-Whitney test. 
ORC5 is an essential gene. Therefore, the temperature sensitive orc5-70 allele was 
used in the senescence curve and orc5-70 and wt cells from the same dissection 
were included as controls. The curve was performed at the semipermissive 
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temperature of 30 °C. The interpretation of the orc5-70 curve is complicated by the 
fact that the temperature sensitive strains orc5-70 est2 and orc5-70 showed a severe 
loss of viability at about 15 PDs and subsequently adapted to the semipermissive 
temperature. Nevertheless, the curve shows that orc5-70 est2 cells do senesce 
faster than est2 cells but the phenotype does not resemble the one shown by rtt101 
est2 cells. 
We conclude that Esc2 and Ctf4 are potential members of Rtt101-assembled 
complexes that might be necessary to promote cell viability in the presence of short 
telomeres. 
3.2.3 Bulk telomere length of rtt101 est2 cells does not differ from bulk 
telomere length of est2 cells during replicative senescence 
Replicative senescence as seen in the est2 or tlc1 mutants is due to cell cycle arrest 
caused by shortening telomeres, which elicit the checkpoint response (Ijpma and 
Greider 2003, Abdallah, Luciano et al. 2009). The premature senescence of rtt101 
est2 cells could be the result of an increased rate of telomere shortening. We 
therefore analysed telomere length of three different rtt101 est2 clones and their 
corresponding est2 mutants originating from the same tetrad using the genomic DNA 
of days 1, 3, 5, and 7 of the senescence curve shown in Figure 13A. Telomere length 
analysis by telomere PCR and by Southern blot of terminal restriction fragments are 
shown in Figure 15(A-C) and reveal that bulk telomere length of rtt101 est2 cells did 
not differ from bulk telomere length of est2 cells during senescence. 
Survivors maintain their telomeres by recombinational processes that lead to very 
heterogeneous telomere length, which results in a telomeric signal smeared through 
the whole lane of a Southern blot as seen in Figure 15D. Telomere length analysis of 
genomic DNA from day 10 (corresponding to 86 PDs approximately) of the 
senescence curve showed no difference between rtt101 est2 and est2 cells. 
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Figure 15 Bulk telomere length of rtt101 est2 cells does not differ from bulk telomere 
length of est2 cells. (A) Representative telomere PCR for telomere 1L and for 6 Y' 
telomeres. The two mutants originate from the same tetrad. (B) Telomere length differences 
between rtt101 est2 and est2 cells as measured by telomere PCR during senescence are 
shown. The mean of differences of three pairs of mutants, each pair originating from one 
tetrad are shown. (C) Telomere length during senescence as measured by Southern blot of 
terminal restriction fragments: genomic DNA of the two mutants originating from the same 
tetrad was digested with XhoI, subjected to Southern blotting followed by hybridization with a 
telomeric probe (D) Southern blot as in (C) for three pairs of mutants after survivor formation. 
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We also measured the telomere length of cells lacking either of the putative Rtt101-
complex members Mms1, Mms22, Esc2, Ctf4, Rtt107 and Crt10 in the presence of 
telomerase by telomere PCR and Southern blot of terminal restriction fragments. 
None of the mutants had telomeres shorter than wt (Supplemental Figure 6). 
3.2.4 Rtt101 might promote a telomere maintenance mechanism required at 
critically short telomeres 
rtt101 cells have been reported to accumulate spontaneous DNA damage that can 
be visualized by an increased number of Ddc1-GFP repair foci in unchallenged 
conditions (Luke, Versini et al. 2006). Like telomere shortening, the accumulation of 
DNA damage can lead to checkpoint activation and cell cycle arrest. In order to test 
whether the premature loss of viability observed in the senescence curves of rtt101 
est2, mms1 est2, mms22 tlc1, ctf4 est2 and esc2 est2 cells was due to a telomere 
length-independent effect of genomic DNA damage accumulation we propagated the 
corresponding telomerase proficient strains in unchallenged conditions. As shown in 
Figure 16A all the tested strains sustained their viability for more than 110 PDs 
indicating that the premature loss of viability observed in the senescence curves is 
indeed due to the lack of telomerase and its consequences. 
The telomere length distribution in wt budding yeast cells in the presence of 
telomerase has been described in detail by Xu and co-workers (Xu 2013). The mean 
telomere length was determined to be 341 ± 41 bp. The mean length of the shortest 
telomere is about 180 bp. Interestingly, the shortest telomere seems to be separated 
by a significant gap of approximately 24 nt from the other telomeres. During 
replicative senescence this gap will most likely be maintained. Indeed, mounting 
evidence suggests that the length of the shortest telomere, not bulk telomere length 
is the major determinant of the onset of replicative senescence (Abdallah, Luciano et 
al. 2009, Khadaroo, Teixeira et al. 2009, Xu 2013). Moreover, it has been proposed 
that depending on their length telomeres elicit different processing pathways during 
replicative senescence, with the shortest telomere being subjected to homologous 
recombination-based (HR) mechanisms that employ the sister chromatid as 
chromatid as a template (Fallet, Jolivet et al. 2014). 
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Figure 16 Possible reasons for the premature senescence of rtt101 est2 cells. (A) In the 
presence of telomerase cells lacking Rtt101 or any of its putative complex members can be 
propagated for more than 110 PDs without viability loss. (B) Senescence curve for rad52 
rtt101 est2 cells compared to rad52 est2 cells. The mean ± s.e.m. of n = 9 cultures per 
genotype are shown. Statisitical testing was performed using the Mann-Whitney test. Three 
stars represent a p-value of p ≤ 0.001. (C) Sequencing of 1L telomere PCR products from 
tetrad 5, day 5 of the rtt101 est2 senescence curve shown in Figure 13A. Open bars 
represent undiverged telomeric sequence, black bars indicate diverged telomeric sequence. 
For rtt101 est2 n = 56 telomeres were sequenced, 7 of which showed divergence. For est2 
n = 64 telomeres were sequenced, 11 of which showed divergence. 
Strikingly, Rtt101, Mms1, Mms22 have been implicated in sister chromatid exchange 
and other less well characterized HR pathways (Baldwin, Berger et al. 2005, Duro, 
Vaisica et al. 2008). Ctf4 is required for sister chromatid cohesion (Hanna, Kroll et al. 
2001). Thus, we speculated that Rtt101 could promote an HR-based repair 
mechanism that might be required specifically at short telomeres to counteract 
shortening and subsequent checkpoint activation. As already described Rad52 plays 
a central role in HR pathways in budding yeast. This predicts that the deletion of 
RTT101 should be epistatic with the deletion of RAD52 EST2 in terms of premature 
senescence. 
We performed the senescence curve comparing the rad52 rtt101 est2 mutant to the 
rad52 est2 mutant to test this prediction (Figure 16B). The viabilities of the two 
mutant strains were almost identical for the greater part of the senescence curve. 
Towards late population doublings, however, viabilities of rad52 rtt101 est2 and 
rad52 est2 cells differed from each other in a statistically significant manner. This is 
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in agreement with Rtt101 promoting a Rad52-dependent mechanism during 
replicative senescence, while also being involved in a Rad52-independent process 
close to crisis. 
Since survivor formation depends on HR-mediated telomere maintenance 
mechanisms, Rad52-deficient cells are unable to overcome crisis and cell cycle 
arrest due to telomere shortening is indeed irreversible. 
In order to test more directly whether Rtt101 promotes an HR-based pathway at 
shortening telomeres we cloned and sequenced telomere 1L of rtt101 est2 and est2 
cells using the genomic DNA extracted from day 5 of the senescence curve shown in 
Figure 13A. Since budding yeast telomeres are composed of imperfect (TG1-3) 
repeats the characteristic telomeric sequence of a particular telomere will be 
maintained in a culture lacking telomerase unless recombination takes place. The 
sequence of telomeres that have recombined usually differs from bulk telomeric 
sequence from a point of divergence onward (Teixeira, Arneric et al. 2004, Chang, 
Dittmar et al. 2011). Our results indicate that telomeric recombination during 
replicative senescence might be reduced. However, the difference between a 
recombination rate of 12.5 % in the rtt101 est2 mutant compared to 17.2 % in the 
est2 mutant is not significant according to Fisher's exact test. 
To collect further evidence that Rtt101 is required at short telomeres and to be able 
to sequence a greater number of critically short telomeres we deleted RTT101 in a 
strain carrying a construct that allows the Galactose-induced shortening of telomere 
7L (Fallet, Jolivet et al. 2014). Unfortunately, the viability of the strain after tetrad 
dissection was too low both in the presence and absence of RTT101 to continue 
experiments (data not shown). 
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Figure 17 RTT101 deletion does not influence the levels of RNA-DNA hybrids at 
telomeres. ChIP with wt and rtt101 cells using S9.6 antibody, which recognizes RNA-DNA 
hybrids. Values are shown as percent input. The mean and SD of three independent 
replicates are shown. The 18S rDNA locus serves as a positive control, since RNA-DNA 
hybrid levels are known to be increased at this locus. 
It has been shown that RNA-DNA hybrids exist at telomeres due to telomeric 
transcription and that RNA-DNA hybrids promote telomere elongation via 
homologous recombination thus delaying the onset of cellular senescence (Balk, 
Maicher et al. 2013). Telomeres start transcribing when they become critically short 
(Cusanelli, Romero et al. 2013). In order to test whether Rtt101 mediates HR by 
promoting hybrid formation we determined the level of RNA-DNA hybrids at 
telomeres in rtt101 cells by ChIP using the S9.6 antibody, which specifically 
recognizes the conformation of an RNA-DNA hybrid independent of its sequence 
(Boguslawski, Smith et al. 1986). No difference in hybrid levels between rtt101 and 
wt cells was detected (Figure 17). This, however, does not rule out the possibility that 
Rtt101 promotes a hybrid-dependent HR pathway, though not by influencing hybrid 
levels. 
3.2.5 Premature senescence of mrc1 est2 cells is epistatic with premature 
senescence of rtt101 est2 
In the first part of this thesis we show that the MMS hypersensitivity of rtt101 cells is 
relieved by the deletion of Mrc1 in a Rad52-dependent manner. Based on genetic 
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evidence we speculated that Rtt101Mms1 might promote the restart of RFs that stalled 
due to MMS-induced lesions. 
Evidence from budding yeast, fission yeast and human cells suggests that telomeres 
are particularly difficult to replicate and replication forks frequently stall in the 
telomeric and subtelomeric region (Makovets, Herskowitz et al. 2004, Miller, Rog et 
al. 2006, Verdun and Karlseder 2006). Replication difficulties are exacerbated when 
telomeres shorten due to the loss of telomeric proteins that facilitate passage of the 
RF (Miller, Rog et al. 2006). In the absence of appropriate repair mechanisms RF 
stalling can lead to RF breakdown and the sudden loss of telomeric tracts. 
We wandered whether Rtt101Mms1 might promote a process at critically short 
telomeres similar to the one at RFs that stalled due to DNA damage and tested if 
MRC1 deletion could rescue the premature senescence phenotype of rtt101 est2 
cells. 
 
Figure 18 Premature senescence of mrc1 est2 cells is epistatic with premature 
senescence of rtt101 est2 cells. Senescence curves for est2, rtt101 est2, mrc1 est2 and 
mrc1 rtt101 est2 cells. All genotypes were retrieved from the dissection of the same diploid. 
The mean and s.e.m of n = 10 cultures are shown. 
The senescence curve in Figure 18 shows that this was not the case. Instead 
mrc1 est2 cells also senesced fast. As in rtt101 est2 cells, premature senescence is 
not due to a global increase in the telomere-shortening rate of telomerase-deficient 
mrc1 cells as has been shown by Grandin and colleagues (Grandin and 
Charbonneau 2007). 
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Interestingly, mrc1 est2 cells were epistatic with rtt101 est2 cells with rtt101 est2 cells 
showing a more severe phenotype. This indicates that the early loss of viability or 
rtt101 est2 cells undergoing replicative senescence is in part due to the absence of 
Mrc1. Preliminary experiments suggest that Mrc1 is indeed stabilized during 
senescence and that Mrc1 stabilization depends on the presence of Rtt101 (data not 
shown). 
This would be in agreement with other studies proposing a protective function of 
Mrc1 from nucleolytic resection by ExoI at uncapped telomeres (Grandin and 
Charbonneau 2007, Tsolou and Lydall 2007). Increased exposition of ssDNA during 
senescence could result in premature checkpoint activation and cell cycle arrest. 
Further experiments are necessary to confirm these observations and to clarify the 
role of Rtt101 in this process. 
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4 Discussion 
4.1 Rtt101 affects the replication stress response through Mrc1 but 
independent of Mrc1's checkpoint function 
In order to identify potential targets of Rtt101-assembled ubiquitin E3 ligase 
complexes we carried out a genetic screen that uncovered 16 suppressor mutations 
that alleviated the hypersensitivity of rtt101 cells to either MMS or CPT or to both 
drugs. We chose to characterize seven of the 16 hits more closely. These hits were 
chosen either due to their strong suppression phenotype or because they had 
previously been implicated in DNA replication and repair pathways. They were: the 
S-phase checkpoint and replication protein Mrc1, the DNA polymerase δ subunit 
Pol32, the 5' flap endonuclease Rad27, Topoisomerase I (Top1), the DNA 
polymerase ε subunit Dpb4, the SUMO E3 ligase Siz2 and the Folylpolyglutamate 
synthetase Met7. 
In a first attempt to identify the complexes, which might mediate target ubiquitination, 
we tested whether the drug sensitivity of the putative Rtt101 complex members 
Mms1 and Mms22 was also relieved by the deletion of the seven selected screen 
hits. 
The deletions of these genes in mms1 cells did indeed result in a rescue signature 
indistinguishable to that of rtt101 cells. Moreover, mms1 cells showed a drug 
sensitivity identical to that of rtt101 cells. This indicates that Mms1 is likely a 
constitutive member of Rtt101-assembled complexes in response MMS and CPT. 
This is in agreement with a wealth of previous studies that could show that the action 
of Rtt101 depended on the presence of its binding partner Mms1 (Zaidi, Rabut et al. 
2008, Ben-Aroya, Agmon et al. 2010, Mimura, Yamaguchi et al. 2010, Han, Zhang et 
al. 2013). In fact, Spt16 is the only target that has been suggested, so far, to be 
ubiquitinated by Rtt101 in the absence of Mms1 (Han, Li et al. 2010). 
The rescue pattern of mms22 cells showed some differences compared to rtt101 
cells, in that: deletion of DPB4 only lead to a slight rescue of mms22 cells on MMS 
and deletion of RAD27 did not rescue mms22 cells on CPT. Moreover, 
hypersensitivity of mms22 cells to MMS, CPT, HU and Zeocin is more severe than 
that of rtt101 and mms1 cells but could be alleviated in all four cases by MRC1 
deletion. Thus, Mms22 appears to be dispensable for the rescue pathway involving 
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Rad27 and of minor importance for the Dpb4 pathway. At the same time Mms22 
function exceeds that of Rtt101 and Mms1 and fulfils a more general function in 
response to a broader range of DNA damage that is also intimately connected to the 
role of Mrc1. This is consistent with the previous suggestions that Mms22 also 
functions outside of the Rtt101 E3 ligase. 
Deletion of MRC1 conferred the most striking rescue of rtt101 cells and, apart from 
the DPB4 and MET7 deletions, was the only suppressor that relieved the 
hypersensitivity of rtt101 cells to both MMS and CPT. Therefore we were particularly 
interested in uncovering the mechanistic details of this pathway and chose to 
characterize it more closely. 
How could Rtt101Mms1Mms22 act in concert to promote cellular viability via Mrc1 
regulation after MMS- and CPT-inflicted DNA damage? Is Mrc1 a direct target of this 
complex? And why could Mrc1 modification or degradation be beneficial to overcome 
DNA damage and replication fork stalling? 
Mrc1, Tof1 and Csm3 were first suggested to be potential targets of an Rtt101 
ubiquitin ligase complex by Collins and co-workers (Collins, Miller et al. 2007) due to 
positive genetic interactions in an epistatic miniarray profile (E-MAP) exploring 
different aspects of chromosome biology, including replication and repair, under 
unchallenged conditions. E-MAPs measure genetic interactions by determining the 
growth rates of double mutants created by the pairwise combination of gene 
deletions. The E-MAP comprises a set of selected genes belonging to a specific 
biological process. 
Our screen results are in agreement with this study while underlining the particular 
and striking positive genetic interaction between RTT101 and MRC1 after damage 
infliction that blocks replication fork progression. Deletion of TOF1 or CSM3 did not 
however, result in positive genetic interaction with RTT101 deletion under these 
conditions (Figure 8). 
Mrc1 has been shown to be ubiquitinated and degraded by the proteasome after 
MMS treatment (Mimura, Komata et al. 2009, Fong, Arumugam et al. 2013). This 
degradation depends partially but not fully on another ubiquitin E3 ligase complex, 
the SCFDia2 complex, which is assembled by the cullin Cdc53 (human CUL1). Just 
like for rtt101 cells, MRC1 deletion rescues MMS sensitivity of dia2 cells and allows 
timely checkpoint downregulation and cell cycle re-entry. It is tempting to speculate 
that the Rtt101Mms1Mms22 complex might be working in a parallel pathway with 
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overlapping function and constitute the so far unknown activity that is required for the 
full reduction of Mrc1 levels during recovery in wt cells. 
This possibility is particularly intriguing since CUL4A and CUL1 have been shown to 
act in concert to ubiquitinate the activated CHK1 protein kinase in human cells (Huh 
and Piwnica-Worms 2013). Rtt101 is thought to be the equivalent of the human 
CUL4 subfamiliy of cullin proteins. Furthermore, CHK1 is activated in a Claspin-
dependent manner in response to DNA damage and CHK1 degradation is required 
for efficient cell cycle re-entry after completion of repair activities. Thus CUL4A and 
CUL1 act together in human cells to promote cell cycle re-entry after MMS-induced 
damage by degrading the effector kinase while the CUL1 homologue Cdc53 
promotes degradation of the mediator molecule Mrc1 together with a so far unknown 
activity in the equivalent situation in budding yeast. 
Two checkpoint defective but replication proficient alleles of Mrc1 have been 
described. In the mrc1-AQ allele all Mec1 target sites are mutated from S/TQ to AQ 
(Osborn and Elledge 2003). The mrc11-971 allele encodes a C-terminally truncated 
version of the protein. Both are able to suppress the MMS sensitivity of dia2 cells just 
as well as full MRC1 deletion. With these results it was concluded that lack of the 
Mrc1 checkpoint function is sufficient to rescue dia2 cells (Fong, Arumugam et al. 
2013). This indicates that the SCFDia2 complex promotes viability after MMS 
treatment by disrupting continued checkpoint signalling during the recovery process 
via destruction of Mrc1. 
Our experiments suggest that unlike deletion of DIA2, deletion of RTT101 does not 
lead to a stabilization of global Mrc1 protein levels during recovery from MMS 
treatment (Figure 11). These preliminary results were corroborated by experiments 
by Vanessa Kellner using a Gal-inducible Mrc1 promoter that allowed targeted shut-
off of protein production (data not shown, published in Buser, Kellner et al. 2016, see 
appendix 7.2). We conclude that Rtt101 does not affect the stability of either global or 
chromatin-associated Mrc1 protein levels (Buser, Kellner et al. 2016). 
More importantly however, the mrc1-AQ allele did not alleviate the drug sensitivity of 
rtt101 cells (Figure 9A). This shows very clearly that unlike for dia2 cells, the lack of 
the Mrc1 checkpoint function is not sufficient to rescue rtt101 cells. Our results do not 
exclude that Rtt101 targets Mrc1. Indeed, we cannot rule out that Mrc1 might be 
ubiquitinated locally or transiently at the site of fork stalling, although we were unable 
to detect such Mrc1 conjugates. However, we exclude that subsequent Mrc1 
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degradation or alteration of function serves the sole purpose of promoting recovery 
by dampening checkpoint signalling. 
4.2 Rtt101 might mediate selective decoupling at stalled replication forks 
through Mrc1 to allow repair and replication fork restart 
Interestingly, the mrc11-971 allele did indeed alleviate MMS sensitivity of rtt101 cells 
almost as well as the full deletion of MRC1 (Figure 9B). Therefore, loss of the 
C-terminal Mrc1 function seems to be crucial.  
The central portion of Mrc1 (Mrc1312-655) has been shown to interact directly with the 
C-terminus of Mcm6, which forms part of the replicative helicase. Mrc1 might also 
interact weakly with Mcm2 and Mcm4 (Komata, Bando et al. 2009). In addition, Mrc1 
has been reported to bind Pol2, the catalytic subunit of the leading strand DNA 
polymerase ε, via two independent interactions. The N-terminus of Mrc1 interacts 
with the N-terminus of Pol2, while the C-terminus of Mrc1 interacts with the 
C-terminus of Pol2. The N-terminal interaction has been implicated in the checkpoint 
response since it is abolished upon phosphorylation of Mrc1, whereas the C-terminal 
interaction is stable also when Mrc1 is phosphorylated (Lou, Komata et al. 2008).  
Coupling of the CMG helicase to the polymerase is crucial for replication of both the 
leading and the lagging strand in challenged and unchallenged conditions. As 
described, leading strand coupling is mediated by Mrc1. Lagging strand coupling 
depends on Ctf4, which trimerizes to bind the CMG helicase subunit Sld5 and 
polymerase α (Miles and Formosa 1992, Gambus, van Deursen et al. 2009, Simon, 
Zhou et al. 2014). 
In the absence of Mrc1 the rate of replication fork progression is reduced and 
replication is slower in these cells (Szyjka, Viggiani et al. 2005, Tourriere, Versini et 
al. 2005, Hodgson, Calzada et al. 2007). After nucleotide depletion due to HU 
treatment the association of Pol2 with replicating DNA is decreased as shown by 
chromatin immunoprecipitation in mrc1 cells (Lou, Komata et al. 2008). The repair or 
restart of stalled replication forks is thought to be curtailed in these cells due to the 
inability to stabilize the blocked replisome. (Katou, Kanoh et al. 2003). Cells lacking 
both Mrc1 and Ctf4 are inviable. Permanent checkpoint activation due to severe 
replication problems prevents cell cycle completion of these cells (Gambus, van 
Deursen et al. 2009). 
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Thus, disruption of the links between the CMG helicase and polymerases ԑ and α 
respectively, have been shown to have deleterious effects. However, several lines of 
evidence indicate that decoupling of the helicase from the polymerase might also be 
beneficial in some special situations such as replicative stress caused by damage-
induced fork stalling. The idea that replisome uncoupling upon blocked RF 
progression might actually be a natural process and a prerequisite for a number of 
subsequent repair pathways has been studied in more detail in E. coli. Yeeles and 
colleagues present the current knowledge on this topic in their review (Yeeles, Poli et 
al. 2013), which served as a basis for the following two paragraphs. 
Damage on the lagging strand is generally thought to be a minor problem for 
replication since repriming of the lagging strand occurs frequently thus allowing 
reinitiation of replication downstream of the lesion and postreplicative repair of the 
unreplicated gap. Several studies using site-specific lagging strand damage showed 
that replication of both the leading and the lagging strand could indeed proceed 
normally despite lagging strand lesions in bacterial systems (McInerney and 
O'Donnell 2004, Nelson and Benkovic 2010). However, lesion bypass does not just 
depend on the ability to reprime. If synthesis continues without removal of the 
replication block then the replisome must allow dissociation and re-binding of the 
stalled polymerase. Unlike its eukaryotic equivalent, the prokaryotic replicative 
helicase travels on the lagging strand template. In this light the results of the above 
mentioned studies indicate that the bacterial replisome is indeed able to decouple the 
helicase from the polymerase activity in a controlled manner. Accordingly, single-
stranded DNA gaps in the lagging strand have been observed by Higuchi and 
colleagues (Higuchi, Katayama et al. 2003) following the introduction of a single DNA 
lesion in an oriC-based replication assay in vitro. 
That repriming of the leading strand is possible in E. coli is supported by mounting 
evidence. Heller and Marians could show that the DnaG primase primed both the 
leading and the lagging strand outside the origin of replication downstream of an 
unrepaired leading strand lesion (Heller and Marians 2006). Yeeles and Marians 
found that introduction of a site specific leading strand damage caused only transient 
fork stalling followed by repriming that depended on DnaG but not on the canonical 
replication restart machinery (Yeeles and Marians 2011). 
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Figure 19 Uncoupling of the CMG helicase from the DNA polymerase ԑ as a common 
step preceding different mechanisms that allow the completion of replication despite 
leading strand damage. Controlled replisome uncoupling has been suggested as a 
prerequisite for various mechanisms including (A) TLS-mediated fork restart (B) leading 
strand repriming and (C) cleavage of the collapsed RF. This figure is shown in the 
introduction of this thesis as Figure 2. It was adapted from (Yeeles, Poli et al. 2013). 
  
 86 
Discussion 
 
  
In eukaryotic systems both the repriming problem and the decoupling problem 
coincide on the leading strand. ssDNA gaps in both the leading and the lagging 
strand and subsequent repair of the gaps has been reported in S. cerevisiae after UV 
irradiation (Lopes, Foiani et al. 2006) and in Xenopus egg extracts in response to 
multiple forms of DNA damage (Byun, Pacek et al. 2005, Van, Yan et al. 2010). 
However, research has primarily focused on the repair pathways overcoming and 
filling these gaps postreplicatively rather than on gap creation. Nevertheless 
replisome uncoupling in order to liberate the CMG helicase from the stalled 
polymerase has been suggested as a common step preceding TLS, template 
switching and BIR (see Figure 19 and (Yeeles, Poli et al. 2013)). The uncoupling 
reaction leads automatically to the production of ssDNA, a potent checkpoint 
activator, which might well be required upstream of a variety of different repair or 
restart mechanisms. Thus, the uncoupling reaction might be concomitantly involved 
in the signalling of a stalled fork (by ssDNA production) and its restart (by gap 
creation that allows direct repriming or other repair pathways, including those based 
on HR). 
Mrc1 is known to mediate both replisome coupling and stalled fork signalling 
presenting itself as the perfect leverage to influence both aspects of replication. Our 
results show that Mrc1 deletion rescues the hypersensitivity of rtt101, mms1 and 
mms22 cells to MMS and CPT. This, in theory, would be in agreement with Mrc1 (or 
an Mrc1 interacting protein) being a target of an Rtt101-assembled E3 ligase 
complex in response to DNA damage-induced replication fork stalling. We suggest 
that ubiquitination of Mrc1 (or an Mrc1 interacting protein) by Rtt101Mms1Mms22 leads to 
uncoupling of the CMG helicase from polymerase ε by disrupting the binding of Mrc1 
to either Mcm6 or Pol2. It is worth mentioning again that the N-terminal interaction of 
Mrc1 and Pol2 is abolished upon Mrc1 phosphorylation by Mec1 (Lou, Komata et al. 
2008) and recent findings of Uzunova and colleagues suggest that Mrc1 is removed 
from chromatin after extended exposure to HU (Uzunova, Zarkov et al. 2014), 
although we were not able to see this upon MMS exposure. Whether Mrc1 
ubiquitination leads to its degradation or simply alters its binding behaviour cannot be 
concluded at the moment and our attempts to detect ubiquitinated Mrc1 conjugates 
have yielded only negative results. Nevertheless, since the rtt101 rescue by MRC1 
deletion depends on RAD52 (Figure 12A), we suggest that modification of Mrc1 by 
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Rtt101 allows HR-based processes to proceed at the uncoupled fork, which promote 
replication fork restart or repair. 
A similar idea has been brought forward in a recent study by Luciano and colleagues 
(Luciano, Dehé et al. 2015). They could show that the high sensitivity of asf1 cells to 
replication stress induced either by CPT or by the deletion of the DNA helicase Rrm3 
is reduced by Ctf4 deletion. Experiments with truncated Ctf4 mutants indicated that it 
is indeed the uncoupling of the CMG helicase from the polymerase α that confers the 
rescue. The histone chaperone Asf1 presents the H3-H4 heterodimer to Rtt109 for 
subsequent acetylation of H3K56. Rtt101, Mms1 and Mms22 have been shown to 
act downstream of the H3 acetylation event (Tong, Lesage et al. 2004, Pan, Ye et al. 
2006, Collins, Miller et al. 2007). While CTF4 deletion could slightly improve viability 
of mms1 and mms22 cells, it aggravated the growth defect of the rtt101 mutant 
caused by MMS treatment. Interestingly, drug sensitivity of asf1 cells was also 
relieved by deletion of MRC1. Experiments with separation of function mutants 
revealed that this effect was due to the loss of Mrc1’s replicative function and 
independent of the absence of Mrc1’s checkpoint function. 
Taken together, the study by Luciano and co-workers indicates that replisome 
uncoupling might be beneficial for cells lacking a functional H3K56 acetylation 
pathway when they face replicative stress. This is in agreement with our results. The 
present thesis complements the understanding of the uncoupling process by 
focussing on the Mrc1-mediated replisome uncoupling and highlighting the role of 
Rtt101 in this process. Moreover, it elucidates the relationship between repair/restart 
mechanisms, which might ensue the uncoupling process, and homologous 
recombination. 
Our results indicate that the rescue of rtt101 and mms1 cells by MRC1 deletion 
requires Rad52 while mms22 cells are at least partially rescued by MRC1 deletion in 
the absence of Rad52 (Figure 12C). Thus Rtt101 probably assembles different 
complexes in response to MMS with different functions. As discussed in section 1.7 
Mms22 is not just a member of Rtt101-assembled ubiquitin E3 ligase complexes. It is 
also degraded by the proteasome in an Rtt101-dependent manner after having been 
recruited to sites of DNA damage and having fulfilled its function there. What exactly 
this function is remains elusive (Ben-Aroya, Agmon et al. 2010). Mass spectrometry 
data from Matthias Peter's lab show that Mms22 binds Mrc1 (Buser, Kellner et al. 
2016, see appendix 7.2). Therefore, Rtt101 could first assemble an E3 ligase 
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complex containing both Mms1 and Mms22, which acts upon Mrc1 to promote 
replisome uncoupling. The Rtt101Mms1 complex might then degrade Mms22 and 
promote recombination at the uncoupled fork by further affecting Mrc1. In this case 
Rtt101 would be acting both upstream and downstream of the decoupling process. 
This model is depicted in Figure 20 (Alternative A). 
Finally, it is also possible that the decoupling step is mediated by Mms22 
independent of Rtt101Mms1 (Figure 20, Alternative B). This would be in agreement 
with Mms22 fulfilling a more general function than Rtt101 and Mms1 in response to 
DNA damage as indicated by the stronger sensitivity of mms22 cells to genotoxic 
agents. Moreover, only mms22 cells but not rtt101 and mms1 cells were rescued on 
HU and Zeocin by MRC1 deletion (Table 1) and the selective decoupling of stalled 
forks might well also be necessary in response to these drugs. 
 
Figure 20 Rtt101 might mediate selective decoupling of the replisome at replication 
forks that have stalled due to DNA lesions. Rtt101Mms1Mms22 could mediate uncoupling of 
the CMG helicase from Polε through the ubiquitination of Mrc1 (Step 1A). Mms22 might then 
be degraded by the Rtt101Mms1 complex as reported before (Step 2). Rtt101Mms1 could then 
promote recombination at the uncoupled fork by further modifying Mrc1. Other repair or 
restart mechanisms might still require replisome uncoupling (Step 1) but are independent of 
further Mrc1 modification and the HR machinery. Alternatively, Step 1 might be mediated by 
Mms22 independent of Rtt101Mms1 (Step 1B).  
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Our results and their interpretation contradict a hypothesis recently published by 
Hang and colleagues (Hang, Peng et al. 2015). They showed that loss of Mrc1 
increases the survival of rtt107, rtt101, mms1 and mms22 cells on MMS containing 
medium and promotes replication completion of rtt107 cells under these conditions. 
They propose that the de-repression of late origins observed in mrc1 cells is 
responsible for the rescue. Indeed, the activation of additional origins in mrc1 cells 
seemed to be independent of the loss of Mrc1’s checkpoint function and could be 
attributed to the loss of Mrc1’s replicative function (Gispan, Carmi et al. 2014). 
However, our experiments indicate clearly that the rescue of rtt101 cells depends on 
a functional HR machinery. Moreover, experiments by Vanessa Kellner using the 
sld3-37A dbf4-4A background suggest that genetic de-repression of late origins is not 
sufficient to alleviate MMS sensitivity of rtt101 mutants (data not shown, published in 
Buser, Kellner et al. 2016, see appendix 7.2), rendering the interpretation of Hang 
and colleagues unlikely.  
Further experiments are certainly necessary to test and develop the ideas suggested 
here and to pinpoint the pathways, both Rad52-dependent and -independent ones, 
that seem to proceed more efficiently in the absence of Mrc1 and suppress the 
hypersensitivity of rtt101, mms1 and mms22 cells to MMS and CPT. 
mms22 cells show reduced HR in response to genotoxic agents while mrc1 cells are 
highly recombinogenic (Baldwin, Berger et al. 2005, Duro, Vaisica et al. 2008). 
Experiments performed in Matthias Peter's lab show that MRC1 deletion alleviates 
the low HR frequency of mms22 cells further indicating that Mrc1 functions 
downstream of Mms22 to suppress HR (Buser, Kellner et al. 2016, see appendix 
7.2). The reduced recombination phenotype observed for mms22 cells is shared by 
rtt101 and mms1 cells in some experimental settings (Duro, Vaisica et al. 2008). 
Co-immunoprecipitation experiments of Mrc1 with Mcm6 (or another component of 
the MCM complex) and Pol2 respectively could elucidate if Mrc1 does indeed 
mediate the selective decoupling of stalled forks after MMS treatment. However, 
since decoupling will only occur at stalled forks it might be difficult to observe 
changes in the interaction when looking at global Mrc1 levels. Therefore, introduction 
of a site-specific replication barrier might facilitate insights into whether or not Mrc1's 
interactions within the replisome change upon fork stalling. Such a system was 
developed for S. cerevisiae in Ian Hickson's lab by introducing the E. coli Tus-Ter 
replication fork barrier into budding yeast (Larsen, Sass et al. 2014). This system 
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would also allow ChIP as an alternative experimental approach to monitor the 
decoupling reaction. Spatial separation of the signals for the CMG helicase and Pol2 
would indicate replisome uncoupling, which might be suppressed in cells lacking 
Rtt101. If selective decoupling proves to be mediated by the Mrc1/Rtt101 system it 
will ultimately be interesting to investigate if Claspin/CUL4 system fulfils a similar 
function in human cells. 
As shown in Figure 9 deletion of the Mrc1 C-terminus rescues rtt101 hypersensitivity 
almost as well as full deletion of MRC1. MRC1 deletion leads to constitutive 
decoupling, which despite its deleterious effects during normal replication seems to 
be beneficial for rtt101 cells during damage-induced replication stress. We just 
argued that this could be due to the fact that constitutive decoupling includes the 
selective decoupling, which might be required for repair or RF restart mechanisms 
including HR-based ones. The mrc11-971 allele shows no defects during normal 
replication (Fong, Arumugam et al. 2013). Therefore, it is unlikely that the replisome 
is constitutively decoupled in mrc11-971 cells. Instead the Mrc1 C-terminus seems to 
be involved in the selective destabilization of Mrc1 or alteration of its binding 
behaviour, thus integrating information and remodelling the replisome accordingly. 
Many Mrc1 binding partners have been found in yeast-two-hybrid assays in budding 
and fission yeast (Zhao, Tanaka et al. 2003, Tanaka and Russell 2004, Lou, Komata 
et al. 2008, Mimura, Komata et al. 2009). Identification of binding partners of the 
Mrc1 C-terminus by yeast-two-hybrid assays using full length Mrc1 and Mrc11-971 
could help to encircle the role of the Mrc1 C-terminus. 
4.3 Rtt101 regulates multiple pathways in response to DNA damage and 
replication stress 
As already described, our screen picked up 16 suppressors of rtt101 drug sensitivity 
(Figure 6F). We tried to uncover the role of Mrc1 in the Rtt101-mediated pathway 
activated in response to damage-induced replication stress as discussed in 
sections 4.1 and 4.2. 
However, our screen results show that Rtt101 is certainly required in a variety of 
pathways in response to DNA damage and replication stress and open up a wealth of 
possible experiments to test and elucidate the connections between Rtt101 and its 
drug sensitivity suppressors. Measuring protein levels of the putative targets in the 
absence and presence of damage-induced replication stress in wt and rtt101 cells 
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while inhibiting protein synthesis will give a first indication of whether the suppressor 
proteins are indeed degraded in an Rtt101-dependent manner. Moreover, the 
presence of the ubiquitinated form of the suppressors in wt and their absence in 
rtt101 cells could be monitored by immunoprecipitation experiments to identify them 
as true targets of Rtt101-assembled ubiquitin E3 ligase complexes. In default of 
these data it is nevertheless worthwhile to speculate about possible Rtt101 functions 
that suggest themselves due to its confirmed drug sensitivity suppressors. In the 
following paragraphs this is done for the six screen hits whose ability to suppress 
drug sensitivity of the putative Rtt101 complex members Mms1, Mms22, Esc2 and 
Ctf4 was tested following the screen. These were the DNA polymerase δ subunit 
Pol32, the 5' flap endonuclease Rad27, Topoisomerase I (Top1), the DNA 
polymerase ε subunit Dpb4, the SUMO E3 ligase Siz2 and the Folylpolyglutamate 
synthetase Met7. 
Pol32 is a subunit of DNA polymerase δ, which synthesizes the lagging strand during 
normal chromosomal DNA replication. Pol32 interacts with Pol31, another Pol δ 
subunit, with the replication clamp proliferating cell nuclear antigen (PCNA, Pol30) 
and with Pol1, the large subunit of polymerase α (Johansson, Garg et al. 2004). For 
translesion synthesis Pol3, the catalytic subunit of Pol δ, is targeted for proteasomal 
degradation by Def1 (Daraba, Gali et al. 2014). This allows the establishment of a 
TLS polymerase called Polζ consisting of Pol32, Pol31, Rev3 (catalytic subunit) and 
Rev7. Interestingly, the assembly of the TLS polymerase is preceded by 
monoubiquitination of PCNA. Disruption of the Pol32-PCNA binding inhibits PCNA 
dependent TLS (Makarova, Stodola et al. 2012). Pol32 is also required for BIR, while 
ubiquitination of PCNA only plays a subordinate role in this process (Lydeard, Lipkin-
Moore et al. 2010). Both processes contribute to genome stability in the face of 
damage-induced replication stress. Our results suggest that ubiquitination by 
Rtt101Mms1Mms22 contributes to the orchestration of one (or both) of these 
mechanisms. Whether this requirement is rooted in degradation or modification of 
Pol32 is not obvious at the moment. 
Rad27 is a 5' flap endonuclease that is involved in the processing of DNA structural 
intermediates that arise during the maturation of Okazaki fragments, in base-excision 
repair and other genome maintenance mechanisms. Interaction of Rad27 with the 
structure-specific endonuclease Mus81-Mms4 stimulates the cleavage of regressed 
replication forks (Kang, Lee et al. 2010) and the resolution of toxic intermediates of 
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HR-based repair (Thu, Nguyen et al. 2015). In the absence of Rad27 stalled RFs 
accumulate (Guo, Qian et al. 2008). Just like Rad27, its human orthologue FEN1 is 
involved in Okazaki fragment processing, DNA repair and other genome 
maintenance pathways. Interestingly, FEN1, has been shown to be degraded at the 
end of S-phase in a proteasome-dependent manner after a cascade of 
phosphorylation, sumoylation and ubiquitination (Guo, Kanjanapangka et al. 2012). 
The action of Rad27 must likely be tightly controlled in yeast, too, in order to prevent 
aberrant nuclease activity, which might threaten genomic integrity. Whether Rad27 is 
indeed ubiquitinated and degraded and whether Rtt101 assembles the corresponding 
ubiquitin E3 ligase complex remains to be determined. 
Topoisomerase I (Top1) relaxes supercoiled DNA by cleaving and resealing the 
phosphodiester backbone. CPT specifically targets Top1 and stabilizes the otherwise 
transient cleavage complex. Collision of the replisome with enzyme-DNA 
intermediate lead to the creation DSBs (Pommier 2013). Thus it is not surprising that 
deletion of the CPT target enzyme Top1 relieves the sensitivity of rtt101 cells to CPT. 
It is noteworthy, however, that the putative Rtt101 complex member Mms22 has 
been shown to be required for the effective cellular response to Etoposide (Baldwin, 
Berger et al. 2005), which stabilizes Topoisomerase II complexes with DNA. mms22 
cells are hypersensitive to topoisomerase II-mediated DNA breaks and Etoposide-
induced homologous recombination is reduced in mms22 cells. Since MMS22 is 
additive with RAD54, Mms22 seems to act outside of the single-strand invasion 
pathway. Baldwin and co-workers also found that MMS22 is epistatic with RTT101 in 
terms of hypersensitivity to Etoposide with MMS22 conferring the more severe 
phenotype. These parallels allow the speculation that Mms22 and Rtt101 are 
required downstream of Etoposide-induced damage and make it interesting to test if 
MRC1 deletion can also relieve the sensitivity of mms22 and rtt101 cells to the 
topoisomerase II poison Etoposide. Finally, studies in mammalian cells suggest that 
Top1 is posttranslationally modified by SUMOylation and ubiquitination and 
consequently degraded in response to CPT treatment (Desai, Liu et al. 1997, Mao, 
Sun et al. 2000). Whether this is also true for yeast, and if Rtt101 plays a role in this 
process remains to be seen. 
Dpb4 is a subunit of DNA polymerase ε. It is noteworthy that Dpb4 and Mrc1 are the 
two suppressors identified in our screen that belong to the part of the replisome 
responsible for leading strand synthesis while at the same time both suppressors are 
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able to alleviate drug sensitivity of rtt101 cells to both MMS and CPT. While the 
functional details of this observation remain elusive at the moment one might 
nevertheless speculate that the Dpb4 and the Mrc1 pathways are interconnected. It 
has indeed been shown that Dpb4 contributes to checkpoint signalling during 
replication stress (Puddu, Piergiovanni et al. 2011). Moreover, replication is disturbed 
in dpb4 cells, probably due to a defective structure of the leading strand polymerase 
Pol ε (Ohya, Maki et al. 2000) and lack of Dpb4 has been suggested to be the cause 
of gaps in the leading strand (Aksenova, Volkov et al. 2010). Thus, Dpb4 might 
contribute to proper Mrc1 function by influencing its interaction with Polε and 
ultimately contribute to replisome coupling. 
The post-translational modifications by ubiquitin and SUMO have been shown to be 
important and often intertwining regulatory signals of the proteins involved in the 
DDR in both yeast and mammalian cells (reviewed in (Bologna and Ferrari 2013, 
Pinder, Attwood et al. 2013)). The SUMOylation of PCNA enhances its subsequent 
ubiquitination by the SUMO-targeted ubiquitin E3 ligase (STUbL) Rad18, which 
monoubiquitinates PCNA (Pol30 in yeast) in responses to DNA damage (Parker and 
Ulrich 2012). This allows the recognition of PCNA by specialised TLS polymerases 
that replicate across the lesion. On the other hand ubiquitin and SUMO target the 
same residue within PCNA and can thus become competing or collaborating PTMs, 
establishing the timing of sequential steps in the progression of replication (Bergink 
and Jentsch 2009). The fact that deletion of the SUMO E3 ligase SIZ2 increases the 
resistance of rtt101 cells to CPT, albeit moderately, might reflect the competition of 
SUMOylation and Rtt101-mediated ubiquitination of a common target in response to 
DNA damage and replication stress. 
Finally the Folylpolyglutamate synthetase Met7 was also among the screen hits. We 
dedicated only limited attention to this suppressor since the met7 mutant showed 
extremely variable growth in unchallenged conditions. Suppression of the petite 
phenotype can be achieved for this mutant by providing exogenous dTMP and 
deleting TUP7 to allow dTMP uptake as reported by DeSouza and colleagues 
(DeSouza, Shen et al. 2000). With MRC1, POL32, RAD27, TOP1 and DPB4, five 
genes identified as suppressor mutations have direct roles in DNA replication and 
repair. Since the levels of Met7 have also been shown to increase upon replication 
stress Met7 might also fall into this category (Cherest 2000, Tkach, Yimit et al. 2012). 
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In summary, our screen results are in agreement with Rtt101 fulfilling a complex and 
manifold role in genome maintenance. Mrc1, Pol32 and Dpb4 are members of the 
replisome. By their modification, Rtt101 could contribute directly to reshaping and 
transforming the replisome in response to replication stress and DNA damage. 
Immunoprecipitation experiments from Matthias Peter's lab show that Rtt101 
interacts with the GINS protein Sld5 during perturbed and unperturbed S-phase 
(Buser, Kellner et al. 2016, see appendix 7.2). Thus Rtt101 might be a constitutive 
member of the active replication machinery implementing some of the changes 
necessary in conditions threatening genomic integrity. On the other hand Rtt101 
might also act beyond remodelling of the stalled RF and interfere with repair 
pathways by targeting members of the DDR such as Rad27 and possibly also Met7 
and Top1. The efficiency of one or several of the Rtt101-mediated pathways might 
also be reduced by SUMOylation in a Siz2-dependent manner. Our screen offers a 
valuable basis for further experiments and also indicates, which complex members 
might be required to help Rtt101 fulfil its different functions in response to damage-
induced replication stress. 
4.4 Rtt101 might suppress precocious senescence signalling by delaying 
the creation of subtelomeric ssDNA through an Mrc1-dependent 
mechanism 
In the second part of this study we tried to elucidate Rtt101's role in preventing the 
premature senescence of budding yeast cells, which had been reported previously by 
the Lydall laboratory (Chang, Lawless et al. 2011). Our data show that bulk telomere 
length in rtt101 est2 cells is not shorter than in est2 cells during senescence 
(Figure 15). Since the length of the shortest telomere determines the onset of 
replicative senescence (Abdallah, Luciano et al. 2009, Khadaroo, Teixeira et al. 
2009, Fallet, Jolivet et al. 2014) Rtt101 might be involved in a telomere maintenance 
mechanism required at critically short telomeres. Epistasis analysis revealed that 
rtt101 rad52 est2 cells are epistatic with rad52 est2 cells during early senescence. 
Towards late population doublings, however, rtt101 rad52 est2 cells lose viability 
significantly faster than rad52 est2 cells indicating that Rtt101 promotes a Rad52-
independent process close to crisis (Figure 16B). This is reminiscent of our results for 
Rtt101's role in response to damage-induced replication stress: on the one hand 
Rtt101 in conjunction with Mms1 seems to allow a Rad52-dependent process to 
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proceed at stalled RFs. On the other hand the hypersensitivity of rtt101 and rad52 
cells is additive suggesting that Rtt101 is also involved in Rad52-independent 
pathways in response to MMS-inflicted damage (Figure 12A and B). 
We also tested putative Rtt101 complex members for their role in senescence and 
found that Mms1, Mms22, Esc2 and Ctf4 senesce prematurely (Figure 14 and Figure 
14). Deletion of MMS1 conferred a senescence phenotype that was strikingly similar 
to the deletion of RTT101. Deletion of MMS22 caused a more severe phenotype than 
deletion of RTT101. Both effects are reminiscent of the situation after damage 
infliction by MMS and CPT. Interestingly, Abdallah and co-workers could show that 
critically short telomeres are kept in a pre-senescent state, in which senescence 
signalling through Mec1 is suppressed by a pathway involving Rad52 and Mms1 
(Abdallah, Luciano et al. 2009). In the presence of Rad52 and Mms1 cells are able to 
divide for several cell divisions despite telomere attrition. The absence of Rad52 or 
Mms1 leads to faster cell cycle arrest but does not affect the size of the critically 
short telomere, which could be followed specifically in this study by using a strain, 
where Flp1-dependent excision of telomeric repeats allowed the controlled creation 
of either a short or a very short 7L telomere. This suggests that the switch from the 
pre-senescent, non-signalling state to the senescence signalling state does not 
involve a further reduction in telomere length but could rely on a structural switch, for 
example the exposure of ssDNA. Since both Rad52 and Mms1 are needed for the 
repair of stalled RFs by sister chromatid recombination (Tsolou and Lydall 2007, 
Duro, Vaisica et al. 2008) the authors speculate that short telomeres require Rad52 
and Mms1 for their replication. Note that sister chromatid recombination would not 
lead to a re-elongation of the shortest telomere. Instead, sister chromatid 
recombination could either maintain the short length or prevent the appearance of 
ssDNA. 
The contribution of Rtt101 to the maintenance of the pre-senescence signalling state 
was not tested in their study. On the basis of the virtually identical premature 
senescence phenotypes of rtt101 est2 and mms1 est2 cells seen in this study and 
the fact that Mms1 seems to constitutively function in conjunction with Rtt101 it 
seems plausible to expand their speculations on Rtt101. Measurement of ssDNA 
throughout the rtt101 est2 and est2 senescence curves could give a first indication if 
Rtt101 prevents premature senescence by the suppression of Mec1 activation 
through ssDNA. 
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The argument brought forward by the Teixeira lab that ssDNA could be the molecular 
structure causing the switch to the senescence signalling state of the critically short 
telomere and that HR factors detain its appearance is supported by mounting 
evidence. RPA has been shown to become enriched at telomeres during replicative 
senescence (Khadaroo, Teixeira et al. 2009). Moreover, Mec1 was identified in 
numerous studies to be one of the checkpoint proteins crucial to trigger cell cycle 
arrest due to telomere attrition (Enomoto, Glowczewski et al. 2002, Ijpma and 
Greider 2003) and ssDNA is a potent Mec1 activator in the DDR. Finally, Rad52 is 
recruited to eroding telomeres (Khadaroo, Teixeira et al. 2009) and the accumulation 
of subtelomeric ssDNA increases specifically at short telomeres of senescing cells in 
the absence of RAD52 (Fallet, Jolivet et al. 2014). 
Two non-exclusive pathways have been suggested by the Teixeira lab as possible 
sources of the exposition of ssDNA. One, 5'-3' resection factors could be active at 
short telomere and two, ssDNA gaps might arise during the replication of short 
telomeres. Indeed, numerous studies have shown that the MRX complex, Sae2 and 
Exo1 act on telomeres during replicative senescence (Ballew and Lundblad 2013, 
Fallet, Jolivet et al. 2014). 
Interestingly, Mrc1 has been shown to prevent the accumulation of ssDNA at 
uncapped telomeres of cdc13-1 and yku70 cells, which was at least partially due to 
Exo1 (Grandin and Charbonneau 2007, Tsolou and Lydall 2007). Since shortening 
telomeres of senescing cells resemble uncapped telomeres due to the progressive 
loss of telomeric binding sites it is tempting to speculate that Mrc1 also protects short 
telomeres from the action of Exo1 and possibly also other nucleases thus preventing 
the accumulation of ssDNA and subsequent Mec1 activation. This would be in 
agreement with the premature senescence of mrc1 est2 cells seen in this study 
(Figure 18) and reported before (Grandin and Charbonneau 2007). 
Our senescence assay showed that the deletions of RTT101 and MRC1 are not 
additive, with rtt101 est2 cells showing a slightly more severe senescence 
phenotype. This indicates that the premature senescence of rtt101 est2 cells is in 
part attributable to loss of the protective function of Mrc1. These data would be in 
agreement with a highly speculative model depicted in Figure 21, in which Rtt101 
stabilizes Mrc1, possibly by degrading Dia2 or another activity targeting Mrc1 for 
destruction, thus suppressing the formation of ssDNA and delaying the activation of 
Mec1 and subsequent cell cycle arrest. 
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Figure 21 Speculative model on how Rtt101 prevents premature senescence in a 
pathway depending on Mrc1. In the absence of telomerase telomeres shorten. Short 
telomeres switch from a pre-senescent, non-signalling state to a senescence-signalling state 
by resection and exhibition of ssDNA that is partially due to Exo1. Mrc1 prevents ssDNA 
accumulation. Rtt101 stabilizes Mrc1 thus preventing precocious senescence signalling. 
Preliminary data by Martina Dees (Luke lab) support the idea that Mrc1 is indeed 
stabilized in est2 cells in an Rtt101-dependent manner. 
How Mrc1 protects uncapped telomeres from the action of nucleases remains to be 
determined. An attractive possibility would be that in the absence of Mrc1 gapped 
molecules or stalled RFs arise during replication of telomeres allowing nucleolytic 
attack and excessive production of ssDNA. In this regard it is noteworthy that the 
5'-3' exonuclease Exo1 is involved in the resection of both uncapped telomeres 
(Maringele and Lydall 2002, Zubko, Guillard et al. 2004) and stalled replication forks 
(Cotta-Ramusino, Fachinetti et al. 2005) highlighting the kinship between these two 
structures (Tsolou and Lydall 2007). This could allow the ubiquitin E3 ligase Rtt101 to 
affect both in different ways that are nevertheless connected by their dependence on 
the replication protein Mrc1: At stalled RFs Rtt101 might mediate selective 
decoupling thus promoting production of ssDNA and gapped molecules for repair and 
RF restart. At eroding telomeres Rtt101 might prevent the premature production of 
ssDNA and precocious cell cycle arrest. 
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4.5 CUL4A is a promising target for cancer treatment 
Complete and faithful chromosome replication is one of the most difficult cellular 
processes. Replication defects are a major source of genomic instability and a very 
early feature in the development of cancer (Yeeles, Poli et al. 2013). The 
Saccharomyces cerevisiae ubiquitin E3 ligase protein Rtt101 is required to cope with 
DNA damage and ensuing replication problems. Rtt101 has also been shown to 
prevent premature replicative senescence. In this study we tried to shed light on both 
aspects of Rtt101 function and could identify Mrc1 as a key protein in mediating 
Rtt101 function. 
Rtt101 is thought to be the functional homologue of the human CUL4 subfamily of 
proteins, which consists of CUL4A and CUL4B. Both CUL4A and CUL4B are 
overexpressed in various types of cancer including primary breast cancer, squamous 
cell carcinomas and adrenocortical carcinomas. High expression levels of CUL4A 
correlate with short patient survival. CUL4A has also been attributed a role in 
carcinogenesis that is not completely understood, but has been linked to its function 
in S-phase, the DDR and cell cycle progression. Two drugs expected to interfere with 
the function of CUL4 and other cullins have been developed as anti-cancer 
therapeutics. The proteasome inhibitor bortezomib has been approved by the US 
Food and Drug administration for the treatment of multiple myeloma. The small 
molecule inhibitor MLN4924, which attenuates cullin activity by preventing cullin 
neddylation, has entered phase I clinical trials for haematological and solid tumour 
malignancies. Due to the side effects, which hamper clinical use of bortezomid, the 
field is currently in search for more selective CUL4A-directed therapeutics. The 
information used in this paragraph was taken from the following reviews (Lee and 
Zhou 2010, Sharma and Nag 2014). 
Senescence has long been accepted as a powerful tumour suppressor mechanism. 
The selective induction of senescence as a mechanism of growth suppression has 
also emerged as a significant strategy in the treatment of cancer, which is exploited 
in various anticancer agents such as cisplatin. Recent studies suggest that 
inactivation of cullin ring ligase (CRL) components also triggers senescence in 
cancer cells. Downregulation of RBX1/ROC1 induces senescence in a variety of 
cancer cell lines including human colon cancer HCT116 cells, lung cancer H1299 
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cells, glioma U87 calls and liver cancer cell lines but the exact mechanism remains 
elusive. The information used in this paragraph was taken from (Pan, Xu et al. 2012). 
RBX1/ROC1 is a constitutive component of CRL4, which has been shown to target 
p21 (Abbas, Sivaprasad et al. 2008, Kim, Starostina et al. 2008). Induction of 
senescence by RBX/ROC1 knockdown depends on p21 in a subset of cell lines. On 
the basis of our data and in analogy with the function of Rtt101 in S. cerevisiae one 
might speculate that the reported induction of senescence might rely on CRL4 and 
Claspin. 
The accuracy and the significance of this speculation remain to be seen. Irrespective 
of this it is uncontested that a sound understanding of the cellular processes in 
response to DNA damage, replication stress and replicative senescence and the 
crosstalk between them in the model system Saccharomyces cerevisiae have the 
potential to also advance our comprehension of these processes in human cells. In 
this study we tried to contribute to this goal by elucidating some aspects of Rtt101's 
role in DNA damage-induced replication stress and replicative senescence. 
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Supplemental Figure 1 Confirmation of screen results: rtt101 cells were crossed to 
seven suppressor mutations. Sensitivities of the double and single mutants to CPT and 
MMS (drugs used in the screen) and to HU and Zeocin were tested. Spottings were 
performed by Martina Dees. 
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Supplemental Figure 2 The effect of rtt101 suppressor mutations on the sensitivity of 
mms1 cells to CPT, MMS, HU and Zeocin was tested. 
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Supplemental Figure 3 The effect of rtt101 suppressor mutations on the sensitivity of 
mms22 cells to CPT, MMS, HU and Zeocin was tested. Spottings were performed by 
Martina Dees. 
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Supplemental Figure 4 The effect of rtt101 suppressor mutations on the sensitivity of 
ctf4 cells to CPT, MMS, HU and Zeocin was tested. The ctf4 mrc1 and ctf4 rad27 double 
mutant were synthetic lethal. 
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Supplemental Figure 5 The effect of rtt101 suppressor mutations on the sensitivity of 
esc2 cells to MMS and Zeocin was tested. The esc2 single mutant is not sensitive to CPT 
and Zeocin. Spottings were performed by Martina Dees. 
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Supplemental Figure 6 Analysis of telomere length in the absence of putative 
members of Rtt101-assembled complexes. Telomere length measurements in the 
presence of telomerase were performed after four consecutive streak outs corresponding to 
approximately 100 PDs. (A) Southern blot of terminal restriction fragments yielded by XhoI 
digest of genomic DNA. Hybridization was done using a telomeric probe. (B) telomere length 
as measured by telomere PCR of telomere 1L and 6 Y' telomeres respectively. The mean 
telomere length and standard deviation of three independent clones are shown. 
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7 Appendix 
 
7.1 Abbreviations 
A        alanine 
AA       amino acid 
Ab       antibody 
ALT       alternative lengthening of telomeres 
APC       anaphase promoting complex 
Arg       arginine 
ATP       adenosine triphosphate 
BER       base excision repair 
BIR       break-induced replication 
bp       base pairs 
CDK       cyclin-dependent kinase 
ChIP       chromatin immunoprecipitation 
CMG      Cdc45-MCM-GINS 
CPT       camptothecin 
CRL       cullin-RING ubiquitin E3 ligase 
CST       Cdc13-Stn1-Ten1 
dCTP      deoxycytidine triphosphate 
dd       double-distilled 
DDR       DNA damage response 
DMSO      dimethyl sulfoxide 
DNA       deoxyribonucleic acid 
dNTP      deoxyribonucleotide 
ds        double-stranded 
DSB       double-strand break 
dTMP      deoxythymidine monophosphate 
E-MAP      epistatic miniarray profile 
EtOH      ethanol 
ExoI       exonuclease I 
FACS      fluorescence-activated cell sorting 
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g        gram 
Gal       galactose 
GCR       gross chromosomal rearrangements 
GFP       green fluorescent protein 
h        hour 
HDR       homology-directed repair 
His       histidine 
HR       homologous recombination 
H. sapiens    Homo sapiens 
HU       hydroxyurea 
Hyg       hygromycin B 
K        lysine 
Kan       kanamycin 
kb        kilobases 
L        litre 
Leu       leucine 
Lys       lysine 
LiAc       lithium acetate 
M        molar 
mg       milligram 
µg       microgram 
MCM      minichromosome maintenance 
mM       millimolar 
MMS      methylmethane sulfonate 
min       minute 
mL       millilitre 
µL       microlitre 
µM       micromolar 
µm       micrometre 
Nat       nourseothricin 
NER       nucleotide excision repair 
ng       nanogram 
NHEJ      non-homologous end joining 
nM       nanomolar 
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nm       nanometre 
nt        nucleotide 
OD       optical density 
PCR       polymerase chain reaction 
PCNA      proliferating cell nuclear antigen 
PD       population doubling 
Pol       polymerase 
PTM       post-translational modification 
Q        glutamine 
RF       replication fork 
RC       replicative complex 
RFC       replication factor C 
rDNA      ribosomal DNA 
RNA       ribonucleic acid 
RNR       ribonucleotide reductase 
RPA       replication protein A 
rpm       rounds per minute 
RT       room temperature 
S        serine 
S. cerevisiae    Saccharomyces cerevisiae 
SCF       Skp1 Cullin F-box 
SD       synthetic dropout 
SDS       sodium dodecyl sulphate 
sec       second 
s.e.m.      standard error of the mean 
SGA       synthetic genetic array 
ss        single-stranded 
S-phase      synthesis phase 
T        threonine 
TLS       translesion synthesis 
TMM      telomere maintenance mechanism 
Top1      topoisomerase I 
TRF       terminal restriction fragment 
Ura       uracil 
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UV       ultra violet 
V        Volt 
wt        wild type 
YPD       yeast extract peptone dextrose  
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